--12-31false0001847112Q3NV 0001847112 2022-12-31 0001847112 2023-09-30 0001847112 2023-07-01 2023-09-30 0001847112 2022-07-01 2022-09-30 0001847112 2023-01-01 2023-09-30 0001847112 2022-01-01 2022-09-30 0001847112 2022-01-01 2022-12-31 0001847112 2021-07-27 0001847112 2023-01-01 2023-03-31 0001847112 2023-04-01 2023-06-30 0001847112 2022-04-01 2022-06-30 0001847112 2021-07-01 2021-07-27 0001847112 2022-01-01 2022-03-31 0001847112 2021-02-01 2021-02-18 0001847112 2023-07-19 2023-07-19 0001847112 2023-02-01 2023-02-01 0001847112 2023-03-09 2023-03-09 0001847112 2023-05-09 2023-05-09 0001847112 2022-12-31 2022-12-31 0001847112 2021-07-19 2021-07-19 0001847112 2023-07-19 0001847112 2023-08-07 0001847112 2023-08-18 0001847112 2021-12-31 0001847112 2023-03-31 0001847112 2023-06-30 0001847112 2022-03-31 0001847112 2022-06-30 0001847112 2022-09-30 0001847112 us-gaap:CommonClassAMember 2023-09-30 0001847112 us-gaap:FairValueInputsLevel2Member trtl:PublicWarrantsMember 2023-09-30 0001847112 us-gaap:FairValueInputsLevel2Member trtl:PrivatePlacementWarrantsMember 2023-09-30 0001847112 trtl:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001847112 trtl:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001847112 trtl:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001847112 trtl:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001847112 trtl:PublicWarrantsMember 2023-09-30 0001847112 us-gaap:IPOMember 2023-09-30 0001847112 us-gaap:OverAllotmentOptionMember 2023-09-30 0001847112 us-gaap:CommonClassBMember 2023-09-30 0001847112 trtl:DeferredLegalFeesAssociatedWithTheInitialPublicOfferingMember 2023-09-30 0001847112 us-gaap:PrivatePlacementMember us-gaap:WarrantMember 2023-09-30 0001847112 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-09-30 0001847112 us-gaap:PrivatePlacementMember 2023-09-30 0001847112 trtl:BusinessCombinationMember 2023-09-30 0001847112 trtl:TransactionAgreementMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-09-30 0001847112 trtl:HcgpMember us-gaap:ConvertibleDebtMember 2023-09-30 0001847112 trtl:IndependentDirectorOneTwoAndThreeMember 2023-09-30 0001847112 trtl:PrivatePlacementWarrantsMember 2023-09-30 0001847112 trtl:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember trtl:PrivatePlacementWarrantsMember 2023-09-30 0001847112 us-gaap:CommonClassAMember trtl:SharePriceEqualOrExceedsTenRupeesPerDollarMember 2023-09-30 0001847112 us-gaap:CommonClassAMember 2022-12-31 0001847112 us-gaap:FairValueInputsLevel1Member trtl:PublicWarrantsMember 2022-12-31 0001847112 us-gaap:FairValueInputsLevel2Member trtl:PrivatePlacementWarrantsMember 2022-12-31 0001847112 trtl:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001847112 trtl:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001847112 trtl:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001847112 trtl:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001847112 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001847112 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001847112 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001847112 trtl:PrivatePlacementWarrantsMember 2022-12-31 0001847112 us-gaap:CommonClassBMember 2022-12-31 0001847112 trtl:DeferredLegalFeesAssociatedWithTheInitialPublicOfferingMember 2022-12-31 0001847112 trtl:IndependentDirectorOneTwoAndThreeMember 2022-12-31 0001847112 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001847112 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001847112 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001847112 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001847112 trtl:IndependentDirectorOneTwoAndThreeMember 2023-07-01 2023-09-30 0001847112 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001847112 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001847112 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001847112 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001847112 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001847112 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001847112 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001847112 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001847112 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001847112 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001847112 us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001847112 us-gaap:IPOMember 2023-01-01 2023-09-30 0001847112 trtl:UnitsEachConsistingOfOneClassAOrdinaryShare00001ParValueAndOnefourthOfOneRedeemableWarrantMember 2023-01-01 2023-09-30 0001847112 trtl:ClassAOrdinarySharesIncludedAsPartOfTheUnitsMember 2023-01-01 2023-09-30 0001847112 trtl:RedeemableWarrantsIncludedAsPartOfTheUnitsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member 2023-01-01 2023-09-30 0001847112 trtl:MonteCarloMember 2023-01-01 2023-09-30 0001847112 us-gaap:PrivatePlacementMember us-gaap:WarrantMember 2023-01-01 2023-09-30 0001847112 trtl:BusinessCombinationMember 2023-01-01 2023-09-30 0001847112 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001847112 trtl:IndependentDirectorOneTwoAndThreeMember 2023-01-01 2023-09-30 0001847112 trtl:SponsorSupportAgreementMember trtl:TrtlMember 2023-01-01 2023-09-30 0001847112 trtl:PrivatePlacementWarrantsMember 2023-01-01 2023-09-30 0001847112 trtl:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember trtl:PrivatePlacementWarrantsMember 2023-01-01 2023-09-30 0001847112 trtl:FromTheCompletionOfBusinessCombinationMember 2023-01-01 2023-09-30 0001847112 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-04-01 2023-06-30 0001847112 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-04-01 2023-06-30 0001847112 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-01-01 2023-03-31 0001847112 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001847112 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001847112 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001847112 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001847112 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001847112 us-gaap:IPOMember 2021-07-01 2021-07-22 0001847112 us-gaap:OverAllotmentOptionMember 2021-07-01 2021-07-27 0001847112 trtl:SecondPrivatePlacementMember us-gaap:WarrantMember 2021-07-01 2021-07-27 0001847112 us-gaap:PrivatePlacementMember us-gaap:WarrantMember 2021-07-01 2021-07-27 0001847112 us-gaap:OverAllotmentOptionMember 2021-07-27 0001847112 us-gaap:PrivatePlacementMember 2023-07-19 0001847112 us-gaap:IPOMember 2021-07-22 0001847112 trtl:RelatedPartyLoansMember 2021-07-22 0001847112 us-gaap:IPOMember 2021-02-01 2021-02-03 0001847112 trtl:RelatedPartyLoansMember 2023-08-07 2023-08-07 0001847112 trtl:RelatedPartyLoansMember 2023-08-18 2023-08-18 0001847112 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001847112 us-gaap:IPOMember 2023-07-01 2023-07-17 0001847112 us-gaap:CommonClassBMember 2021-02-01 2021-02-28 0001847112 us-gaap:CommonClassBMember 2021-02-18 2021-02-18 0001847112 us-gaap:CommonClassAMember 2021-02-18 2021-02-18 0001847112 us-gaap:CommonClassBMember 2021-02-28 0001847112 us-gaap:CommonClassBMember 2021-07-27 2021-07-27 0001847112 trtl:ExtraordinaryGeneralMeetingHeldToExtendTheDateByWhichBusinessCombinationShallBeConsummatedMember us-gaap:SubsequentEventMember 2023-10-19 2023-10-19 0001847112 us-gaap:SubsequentEventMember trtl:SponsorMember 2023-10-19 2023-10-19 0001847112 trtl:ExtraordinaryGeneralMeetingHeldToExtendTheDateByWhichBusinessCombinationShallBeConsummatedMember us-gaap:SubsequentEventMember 2023-10-19 0001847112 trtl:MathewSchindelMember trtl:NominationAndRemunerationCommitteeMember us-gaap:CommonClassBMember 2023-07-31 0001847112 trtl:AndrewLipsherMember trtl:CompensationCommitteeMember us-gaap:CommonClassBMember 2023-07-31 0001847112 trtl:JackLeeneyMember trtl:AuditCommitteeMember us-gaap:CommonClassBMember 2023-07-31 0001847112 trtl:IndependentDirectorThreeMember 2023-07-31 0001847112 trtl:IndependentDirectorTwoMember 2023-07-31 0001847112 trtl:IndependentDirectorOneMember 2023-07-31 0001847112 trtl:AuditCommitteeMember 2023-07-31 0001847112 trtl:FounderSharesMember 2021-02-01 2021-02-09 0001847112 us-gaap:CommonClassBMember trtl:FounderSharesMember 2021-02-01 2021-02-09 0001847112 us-gaap:CommonClassBMember 2021-02-01 2021-02-18 0001847112 us-gaap:OverAllotmentOptionMember 2021-02-01 2021-02-18 0001847112 us-gaap:CommonClassBMember 2021-02-18 0001847112 srt:MaximumMember trtl:BusinessCombinationAgreementMember trtl:OneEnergyMember trtl:TrtlMember 2023-08-14 2023-08-14 0001847112 srt:MinimumMember trtl:BusinessCombinationAgreementMember trtl:OneEnergyMember trtl:TrtlMember 2023-08-14 2023-08-14 0001847112 trtl:ContingentStockRightsAgreementMember trtl:TrtlMember 2023-08-14 2023-08-14 0001847112 trtl:SponsorSupportAgreementMember trtl:TrtlMember 2023-08-14 2023-08-14 0001847112 trtl:BusinessCombinationAgreementMember trtl:OneEnergyMember trtl:TrtlMember trtl:EarnoutConditionTwoMember 2023-08-14 2023-08-14 0001847112 trtl:TrtlMember trtl:EarnoutConditionOneMember trtl:OneEnergyMember trtl:BusinessCombinationAgreementMember 2023-08-14 2023-08-14 0001847112 trtl:BusinessCombinationAgreementMember trtl:OneEnergyMember trtl:TrtlMember trtl:EarnoutConditionTwoMember 2023-08-14 0001847112 trtl:TrtlMember trtl:EarnoutConditionOneMember trtl:OneEnergyMember trtl:BusinessCombinationAgreementMember 2023-08-14 0001847112 trtl:ContingentStockRightsAgreementMember trtl:TrtlMember 2023-08-14 0001847112 us-gaap:SubsequentEventMember trtl:SponsorMember trtl:ExtensionNoteMember 2023-10-20 0001847112 us-gaap:SubsequentEventMember trtl:ExtraordinaryGeneralMeetingHeldToExtendTheDateByWhichBusinessCombinationShallBeConsummatedMember 2023-10-20 0001847112 us-gaap:CommonClassAMember 2023-11-13 0001847112 us-gaap:CommonClassBMember 2023-11-13 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-09-30 0001847112 us-gaap:RetainedEarningsMember 2023-09-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-09-30 0001847112 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-09-30 0001847112 us-gaap:RetainedEarningsMember 2022-09-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-09-30 0001847112 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-06-30 0001847112 us-gaap:RetainedEarningsMember 2023-06-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-06-30 0001847112 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-12-31 0001847112 us-gaap:RetainedEarningsMember 2022-12-31 0001847112 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-03-31 0001847112 us-gaap:RetainedEarningsMember 2023-03-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-03-31 0001847112 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001847112 us-gaap:RetainedEarningsMember 2021-12-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0001847112 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-03-31 0001847112 us-gaap:RetainedEarningsMember 2022-03-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-03-31 0001847112 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-06-30 0001847112 us-gaap:RetainedEarningsMember 2022-06-30 0001847112 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-06-30 0001847112 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 iso4217:USD xbrli:shares utr:Year xbrli:pure utr:Day iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
 
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                  
Commission File
Number: 001-40633    
 
 
TORTOISEECOFIN ACQUISITION CORP. III
(Exact Name of Registrant as Specified in its Charter)
 
 
 
Cayman Islands
  
98-1583266
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification No.)
195 US HWY 50, Suite 208
Zephyr Cove, NV
  
89448
(Address of principal executive offices)
  
(Zip Code)
(913)
981-1020
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange
on which registered
Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and
one-fourth
of one redeemable warrant
  
TRTL.U
  
New York Stock Exchange
Class A Ordinary Shares included as part of the units
  
TRTL
  
New York Stock Exchange
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
  
TRTL WS
  
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
Non-accelerated
filer		   ☒    Smaller reporting company   ☒
Emerging growth company   ☒     
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☒    No  ☐
As of November
13
, 2023, 17,264,702 Class A ordinary shares, par value $0.0001 per share, and 8,625,000 Class B ordinary shares, par value $0.0001 per share, were issued and outstanding.
 
 
 

TORTOISEECOFIN ACQUISITION CORP. III

Quarterly Report on Form 10-Q

Table of Contents

 

         Page No.  

PART I. FINANCIAL INFORMATION

     1  

Item 1.

   Financial Statements      1  
 

Condensed Consolidated Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022

      1  
 

Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022

      2  
 

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2023 and 2022

      3  
 

Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022

      4  
 

Notes to Unaudited Condensed Consolidated Financial Statements

      5  

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations      22  

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk      26  

Item 4.

   Controls and Procedures      26  

PART II. OTHER INFORMATION

     27  

Item 1.

   Legal Proceedings      27  

Item 1A.

   Risk Factors      27  

Item 2.

   Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.      27  

Item 3.

   Defaults Upon Senior Securities      27  

Item 4.

   Mine Safety Disclosures      27  

Item 5.

   Other Information      27  

Item 6.

   Exhibits      27  

 

i

http://fasb.org/us-gaap/2023#RelatedPartyMemberhttp://fasb.org/us-gaap/2023#RelatedPartyMemberP20DP20DP30DP30D
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
TORTOISEECOFIN ACQUISITION CORP. III
CONDENSED CONSOLIDATED BALANCE SHEETS
 
    
September 30,
2023
    
December 31,
2022
  
    
(Unaudited)
        
Assets
     
Current assets:
     
Cash
    $ 13,137     $ 78,997  
Prepaid expenses
      193,312       421,809  
  
 
 
    
 
 
  
Total current assets
   
 
206,449
 
  
 
500,806
 
Cash and investments held in Trust Account
      361,349,195       349,991,153  
  
 
 
    
 
 
  
Total Assets
   
$
361,555,644
 
  
$
350,491,959
 
  
 
 
    
 
 
  
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
     
Current liabilities:
     
Accounts payable
    $ 834,481     $ 30,076  
Accrued expenses
      564,344       120,960  
  
 
 
    
 
 
  
Total current liabilities
   
 
1,398,825
 
  
 
151,036
 
Promissory note – related party
      335,000       —  
Convertible promissory note
      380,000       —  
Due to related party
      53,333       —  
Deferred legal fees
      173,667       173,667  
Deferred underwriting commissions
      7,245,000       12,075,000  
Derivative warrant liabilities
      2,644,917       3,111,667  
  
 
 
    
 
 
  
Total Liabilities
   
 
12,230,742
 
  
 
15,511,370
 
Commitments and Contingencies
     
Class A ordinary shares subject to possible redemption, $0.0001 par value; 34,500,000 shares issued and outstanding at approximately $10.47 and $10.14 at September 30, 2023 and December 31, 2022, respectively
      361,249,195       349,891,153  
Shareholders’ Deficit
     
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at September 30, 2023 and December 31, 2022
      —       —  
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no
non-redeemable
shares issued or outstanding at September 30, 2023 and December 31, 2022
      —       —  
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding at September 30, 2023 and December 31, 2022
      863       863  
Accumulated deficit
      (11,925,156 )      (14,911,427 ) 
  
 
 
    
 
 
  
Total shareholders’ deficit
   
 
(11,924,293
) 
  
 
(14,910,564
) 
  
 
 
    
 
 
  
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
   
$
361,555,644
 
  
$
350,491,959
 
  
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
1
TORTOISEECOFIN ACQUISITION CORP. III
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
    
For the Three Months Ended
September 30,
    
For the Nine Months Ended
September 30,
  
    
2023
    
2022
    
2023
    
2022
  
General and administrative expenses
    $ 1,231,170     $ 381,915     $ 2,220,479     $ 1,312,022  
Administrative expenses – related party
      30,000       30,000       90,000       90,000  
  
 
 
    
 
 
    
 
 
    
 
 
  
Loss from operations
   
 
(1,261,170
) 
  
 
(411,915
) 
  
 
(2,310,479
) 
  
 
(1,402,022
) 
Other income:
         
Change in fair value of derivative warrant liabilities
      (1,927,677 )      1,867,000       466,750       11,046,416  
Other income attributable to derecognition of deferred underwriting fee allocated to offering costs
      205,275       —         205,275       —    
Interest income from cash and investments held in Trust Account
      3,816,900       1,557,255       11,358,042       2,072,605  
  
 
 
    
 
 
    
 
 
    
 
 
  
Total other income
      2,094,498       3,424,255       12,030,067       13,119,021  
Net income
   
$
833,328
 
  
$
3,012,340
 
  
$
9,719,588
 
  
$
11,716,999
 
  
 
 
    
 
 
    
 
 
    
 
 
  
Weighted average number of Class A ordinary shares - basic and diluted
      34,500,000       34,500,000       34,500,000       34,500,000  
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted net income per share, Class A ordinary shares
    $ 0.02     $ 0.07     $ 0.23     $ 0.27  
  
 
 
    
 
 
    
 
 
    
 
 
  
Weighted average number of Class B ordinary shares - basic and diluted
      8,625,000       8,625,000       8,625,000       8,625,000  
  
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted net income per share, Class B ordinary shares
    $ 0.02     $ 0.07     $ 0.23     $ 0.27  
  
 
 
    
 
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
2
TORTOISEECOFIN ACQUISITION CORP. III
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023
 
    
Ordinary Shares
     
Additional
           
Total
  
    
Class A
     
Class B
     
Paid-in
     
Accumulated
    
Shareholders’
  
    
Shares
     
Amount
     
Shares
     
Amount
     
Capital
     
Deficit
    
Deficit
  
Balance - December 31, 2022
   
 
—  
 
   
$
—  
 
   
 
8,625,000
 
   
$
863
 
   
$
—  
 
   
$
(14,911,427
) 
  
$
(14,910,564
) 
Increase in redemption value of Class A ordinary shares subject to possible redemption
      —          —          —          —          —          (3,713,581 )      (3,713,581 ) 
Net income
      —          —          —          —          —          4,910,691       4,910,691  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - March 31, 2023 (unaudited)
   
 
—  
 
   
 
—  
 
   
 
8,625,000
 
   
 
863
 
   
 
—  
 
   
 
(13,714,317
) 
  
 
(13,713,454
) 
Increase in redemption value of Class A ordinary shares subject to possible redemption
      —          —          —          —          —          (3,827,561 )      (3,827,561 ) 
Net income
      —          —          —          —          —          3,975,569       3,975,569  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - June 30, 2023 (unaudited)
   
 
—  
 
   
 
—  
 
   
 
8,625,000
 
   
 
863
 
   
 
—  
 
   
 
(13,566,309
) 
  
 
(13,565,446
) 
Increase in redemption value of Class A ordinary shares subject to possible redemption
      —          —          —          —          —          807,825       807,825  
Net income
      —          —          —          —          —          833,328       833,328  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - September 30, 2023 (unaudited)
   
 
—  
 
   
$
—  
 
   
 
8,625,000
 
   
$
863
 
   
$
—  
 
   
$
(11,925,156
) 
  
$
(11,924,293
) 
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022
 
    
Ordinary Shares
     
Additional
           
Total
  
    
Class A
     
Class B
     
Paid-in
     
Accumulated
    
Shareholders’
  
    
Shares
     
Amount
     
Shares
     
Amount
     
Capital
     
Deficit
    
Deficit
  
Balance - December 31, 2021
   
 
—  
 
   
$
—  
 
   
 
8,625,000
 
   
$
863
 
   
$
  —   
 
   
$
(24,239,996
) 
  
$
(24,239,133
) 
Net income
      —          —          —          —          —          5,811,814       5,811,814  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - March 31, 2022 (unaudited)
   
 
—  
 
   
 
—  
 
   
 
8,625,000
 
   
 
863
 
   
 
—  
 
   
 
(18,428,182
) 
  
 
(18,427,319
) 
Increase in redemption value of Class A ordinary shares subject to possible redemption
      —          —          —          —          —          (415,350 )      (415,350 ) 
Net income
      —          —          —          —          —          2,892,845       2,892,845  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - June 30, 2022 (unaudited)
   
 
—  
 
   
 
—  
 
   
 
8,625,000
 
   
 
863
 
   
 
—  
 
   
 
(15,950,687
) 
  
 
(15,949,824
) 
Increase in redemption value of Class A ordinary shares subject to possible redemption
      —          —          —          —          —          (1,557,255 )      (1,557,255 ) 
Net income
      —          —          —          —          —          3,012,340       3,012,340  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - September 30, 2022 (unaudited)
   
 
—  
 
   
$
—  
 
   
 
8,625,000
 
   
$
863
 
   
$
—  
 
   
$
(14,495,602
) 
  
$
(14,494,739
) 
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
3
TORTOISEECOFIN ACQUISITION CORP. III
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
    
For the Nine Months Ended
September 30,
  
    
2023
    
2022
  
Cash Flows from Operating Activities:
     
Net income
    $ 9,719,588     $ 11,716,999  
Adjustments to reconcile net income to net cash used in operating activities:
     
Change in fair value of derivative warrant liabilities
      (466,750 )      (11,046,416 ) 
Other income attributable to derecognition of deferred underwriting fee allocated to offering costs
      (205,275 )   
Interest income from cash and investments held in Trust Account
      (11,358,042 )      (2,072,605 ) 
Changes in operating assets and liabilities:
     
Prepaid expenses
      228,497       547,594  
Due to related party
      53,333       —  
Accounts payable
      804,405       10,887  
Accrued expenses
      443,384       (2,467 ) 
  
 
 
    
 
 
  
Net cash used in operating activities
   
 
(780,860
) 
  
 
(846,008
) 
  
 
 
    
 
 
  
Cash Flows from Financing Activities:
     
Proceeds from promissory note- related party
      335,000       —  
Proceeds from convertible note payable to related parties
      380,000       —  
  
 
 
    
 
 
  
Net cash provided by operating activities
   
 
715,000
 
  
 
—
 
  
 
 
    
 
 
  
Net change in cash
      (65,860 )      (846,008 ) 
Cash – beginning of the period
      78,997       1,174,867  
  
 
 
    
 
 
  
Cash – end of the period
   
$
13,137
 
  
$
328,859
 
  
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
4
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION
TortoiseEcofin Acquisition Corp. III (the “Company”) was incorporated as a Cayman Islands exempted company on February 3, 2021. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
The Company has one wholly-owned subsidiary, TRTL III Merger Sub Inc., a Delaware corporation (“Merger Sub”), which was formed for the sole purpose of the consummation of a potential business combination (the “Transactions”) between the Company and One Energy Enterprises Inc., a Delaware corporation (“One Energy”) (see Note 5).
All activity for the period from February 3, 2021 (inception) through September 30, 2023 relates to the Company’s formation and its initial public offering (the “Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, the search for a prospective acquisition for an initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company may generate
non-operating
income in the form of interest income on cash and investments held in trust from the proceeds of its Initial Public Offering. The Company’s fiscal year end is December 31.
The Company’s sponsor is TortoiseEcofin Sponsor III LLC, a Cayman Islands limited liability company (the “Sponsor”), which is owned by Hennessy Capital Growth Partners Fund I SPV V, LLC, a Delaware limited liability company (“HCGP”), and the Company’s management (directly or indirectly, including through family trusts). The registration statement for the Company’s Initial Public Offering was declared effective on July 19, 2021. On July 22, 2021, the Company consummated its Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $28.3 million, of which $10.5 million was for deferred underwriting commissions (see Note 5) and $11.1 million was the excess of fair value over price paid for Founder Shares sold to certain qualified institutional buyers or institutional accredited investors (the “Anchor Investors”). On July 23, 2021, the underwriters exercised their over-allotment option in full and on July 27, 2021, they purchased 4,500,000 additional Units, generating gross proceeds of $45.0 million (the “Over-Allotment”), and incurring offering costs of approximately $2.5 million, of which approximately $1.6 million was for deferred underwriting commissions. Approximately $1.3 million of the offering costs were allocated to derivative warrant liabilities. The Anchor Investors purchased 32,400,000 Units in the Initial Public Offering and the Over-Allotment. None of the Anchor Investors are affiliated with any member of the Company’s management.
Simultaneously with the closing of the Initial Public Offering, the Company completed the sale of 6,333,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) in a private placement (the “Private Placement”), at a price of $1.50 per Private Placement Warrant, to TortoiseEcofin Borrower LLC, a Delaware limited liability company (“TortoiseEcofin Borrower”), generating proceeds of $9.5 million (see Note 4). Concurrently with the consummation of the Over-Allotment on July 27, 2021, TortoiseEcofin Borrower purchased 600,000 additional Private Placement Warrants, generating proceeds of $900,000 (the “Second Private Placement”). Pursuant to that certain securities purchase agreement, dated as of July 19, 2023, HCGP acquired from TortoiseEcofin Borrower all of its limited liability company interests in the Sponsor, as well as 5,893,333 Private Placement Warrants of the Company held by TortoiseEcofin Borrower.
Upon the closing of the Initial Public Offering and the Private Placement on July 22, 2021, and the Over-Allotment and the Second Private Placement on July 27, 2021, the net proceeds thereof consisting of $345.0 million ($10.00 per Unit) were placed in a trust account (the “Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and may be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule
2a-7
of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
 
5
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The Company’s management (“management”) has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, the Over-Allotment and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination, and a majority of the independent directors must approve such initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide the holders (the “Public Shareholders”) of Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes). The
per-share
amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares are classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which the Company adopted in connection with the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) and HCGP agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering, and the Anchor Investors agreed to vote any Founder Shares held by them, in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company adopted an insider trading policy which requires insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material
non-public
information and (ii) clear all trades with the Company’s legal counsel prior to execution. In addition, HCGP and the initial shareholders agreed that they will not be entitled to redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
Notwithstanding the foregoing, if the Company seeks shareholder approval of its Business Combination and does not conduct redemptions in connection with its Business Combination pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.
At the time of the Initial Public Offering, the Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association that would modify the substance or timing of the Company’s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with a Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete its Business Combination within 24 months from the closing of the Initial Public Offering, or July 22, 2023, or 27 months from the closing of the Initial Public Offering, or October 22, 2023, if the Company executed a letter of intent, agreement in principle or definitive agreement for an initial Business Combination within 24 months from the closing of the Initial Public Offering but has not completed the initial Business Combination within such
24-month
period or with respect to any other provision relating to the rights of Public Shareholders, unless the Company will provide the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. On July 20, 2023, the Company issued a press release announcing that it had executed a new
non-binding
letter of intent for a proposed business combination with an industrial renewable power solutions company (the “Letter of Intent”). As a result of the signed Letter of Intent, pursuant to the provisions of the Company’s Amended and Restated Memorandum and Articles of Association, the date by which the Company must consummate its Business Combination was automatically extended from July 22, 2023 to October 22, 2023.
On October 19, 2023, the Company held an extraordinary general meeting in lieu of an annual general meeting of shareholders (the “Extension Meeting”) and filed an amendment to the Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate an initial Business Combination from October 22, 2023 on a monthly basis up to six times until April 22, 2024 (or such earlier date as determined by the board of directors of the Company (the “Board”)). The Company will deposit $258,970.53 per month into the Trust Account, for each calendar month (commencing on October 23, 2023 and on the 23
rd
day of each subsequent month) until April 22, 2024, or portion thereof, that is needed to complete an initial Business Combination. As a result, the date by which the Company must consummate its Business Combination was extended from October 22, 2023 to November 22, 2023 (the “Combination Period”).
 
6
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The Anchor Investors are not entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of a Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a shareholder vote to amend the Amended and Restated Memorandum and Articles of Association in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated a Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete a Business Combination within the Combination Period).
If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses and net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish the Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Board, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
HCGP and the initial shareholders agreed to waive their liquidation rights with respect to the Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. Three of the four underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account with respect to the Company’s Letter of Intent for a proposed business combination with an industrial renewable power solutions company, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
On July 16, 2023, each of Juan J. Daboub, Mary Beth Mandanas and Greg A. Walker resigned from the Board and all committees thereof. None of Mr. Daboub’s, Ms. Mandanas’ or Mr. Walker’s resignation was a result of any disagreement with the Company or the Board on any matters related to the Company’s operation, policies or practices.
In connection with each of Mr. Daboub’s, Ms. Mandanas’ and Mr. Walker’s resignation and in accordance with the terms of the arrangement to which each of them agreed at the time of their respective appointment to the Board, each of Mr. Daboub, Ms. Mandanas and Mr. Walker forfeited to the Company all of the Class B ordinary shares, par value $0.0001 per share, which were previously issued to them in connection with their appointment to the Board.
On July 19, 2023, the Board appointed Thomas D. Hennessy as a director of the Company, effective immediately. Mr. Hennessy replaced Stephen Pang, who resigned as a director of the Company on the same day. Mr. Pang’s resignation was not the result of any disagreement with the Company or the Board. Mr. Pang continues in his positions as President and Chief Financial Officer of the Company.
In addition, Steven Schnitzer resigned as the Vice President, General Counsel and Secretary of the Company on the same day. Mr. Schnitzer’s resignation was not the result of any disagreement with the Company or the Board.
On July 17, 2023, three of the four underwriters for the Company’s Initial Public Offering, consisting of Barclays Capital Inc., Goldman Sachs & Co. LLC and Academy Securities, Inc., agreed to waive all rights to their respective portion of the underwriting commissions (or approximately $9.96 million of the total $12.075 million of the underwriting commissions) with respect to the Company’s proposed Business Combination. As of September 30, 2023, one of the underwriters had further agreed to waive all rights to their respective portion of the underwriting commissions (approximately $4.83 million) with respect to the Company’s proposed Business Combination or to any future Business Combination.
Pursuant to that certain securities purchase agreement, dated as of July 19, 2023, HCGP acquired from TortoiseEcofin Borrower all of its limited liability company interests in the Sponsor, as well as 5,893,333 Private Placement Warrants of the Company held by TortoiseEcofin Borrower. In connection with the transaction, HCGP assumed Tortoise Capital Advisors, L.L.C.’s (“Tortoise Capital Advisors”) rights and obligations under the Administrative Support Agreement (see Note 4).
On July 31, 2023, the Board appointed Jack Leeney, Andrew Lipsher and Matthew Schindel as directors of the Company, effective immediately. Each of the directors serve on the audit, compensation and nominating and corporate governance committees of the Board with Mr. Leeney serving as chair of the compensation committee, Mr. Lipsher serving as chair of the nominating and corporate governance committee, and Mr. Schindel serving as chair of the audit committee. As compensation for their services, the directors will each receive 20,000 Class B ordinary shares of the Company and will also be entitled to cash compensation of $25,000 per quarter.
On September 27, 2023, Darrell Brock, Jr. submitted his resignation as Vice President, Business Development, of the Company, effective immediately. There were no disagreements between the Company and Mr. Brock on any matter related to the Company’s operations, policies, or practices.
 
7
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Liquidity, Capital Resources and Going Concern
As of September 30, 2023, the Company had approximately $13,000 in operating cash and a working capital deficit of approximately $1,192,000.
The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in consideration of Founder Shares, and a loan from the Sponsor of approximately $195,000, under the Note (as defined in Note 4). The Company repaid the Note in full on July 22, 2021 and borrowings under the Note are no longer available.
Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds of $3.5 million from the consummation of the Initial Public Offering, the Over-Allotment, the Private Placement and the Second Private Placement held outside of the Trust Account. In addition, in order to finance general working capital needs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On February 1, 2023, the Company issued a nonconvertible, unsecured promissory note (the “2023 Note”) in the principal amount of $500,000 to TortoiseEcofin Borrower. The 2023 Note does not bear interest and is repayable in full upon consummation of a Business Combination. If the Company does not complete a Business Combination, the 2023 Note will not be repaid and all amounts owed under it will be forgiven. On July 19, 2023, The Company issued a promissory note (the “HCGP Note”) in the principal amount of up to $1,000,000 to HCGP. The HCGP Note was issued in connection with advances HCGP may make in the future to the Company for working capital expenses. The HCGP Note bears no interest and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the election of HCGP, all or a portion of the unpaid principal amount of the HCGP Note may be converted into warrants of the Company at a price of $1.50 per warrant (the “Conversion Warrants”). The Conversion Warrants and their underlying securities are entitled to the registration rights set forth in the HCGP Note. On August 7, 2023 and August 18, 2023, the Company borrowed $100,000 and $280,000, respectively, under the HCGP Note. See Note 4. As of September 30, 2023 and December 31, 2022, there were $335,000 and $0, respectively, outstanding under Working Capital Loans.
In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC
Topic 205-40,
“Presentation of Financial Statements-Going Concern,” management has determined that the liquidity condition and mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. The Company intends to complete a Business Combination before the mandatory liquidation date of November 22, 2023; however, there can be no assurance that the Company will be able to consummate a Business Combination by the Combination Period. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the Combination Period. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 or any future period.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form
10-K
filed by the Company with the SEC on March 22, 2023.
 
8
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Merger Sub. There has been no intercompany activity since inception.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of September 30, 2023 and December 31, 2022.
Investments and Cash Held in Trust Account
On June 14, 2023, the Company liquidated the U.S. government treasury obligations or money market funds held in the Trust Account. The funds in the Trust Account are currently maintained in cash in an interest-bearing demand deposit account at a bank until the earlier of consummation of the Company’s initial Business Combination and liquidation. Prior to June 14, 2023, the Company’s portfolio of investments was comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the unaudited condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of September 30, 2023 and December 31, 2022, the Company had approximately $361.3 million and $350.0 million in cash held in the Trust Account, respectively.
 
9
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Fair Value of Financial Instruments
The carrying value of the Company’s assets and liabilities recognized in the condensed consolidated balance sheets, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the fair values for such assets and liabilities either because of the short-term nature of the instruments or because the instrument is recognized at fair value.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued warrants to purchase shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The warrants issued in connection with the Initial Public Offering and the Over-Allotment (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value will be recognized in the Company’s statement of operations. The fair value of the Public Warrants and the Private Placement Warrants were initially measured at fair value using a Black-Scholes Option Pricing Method and Monte Carlo simulation, respectively. Subsequent to the Public Warrants being separately listed and traded from the Units, the fair value of the Public Warrants was measured based on their listed market price, and the fair value of the Private Placement Warrants was estimated by reference to the listed market price of the Public Warrants. The determination of the fair value of the warrant liabilities may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as
non-current
liabilities as their liquidation will not be reasonably expected to require the use of current assets or require the creation of current liabilities.
 
10
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Offering Costs Associated with Initial Public Offering
Offering costs consists of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to the total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as
non-operating
other income in the unaudited condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares issued were charged against their carrying value upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption
As discussed in Note 1, all of the 34,500,000 Class A ordinary shares sold as part of the Units in the Initial Public Offering and the Over-Allotment contain a redemption feature which allows for the redemption of the Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Amended and Restated Memorandum and Articles of Association. In accordance with ASC 480, conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, as of September 30, 2023 and December 31, 2022, all 34,500,000 Class A ordinary shares subject to possible redemption at the redemption amount are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
Under ASC
480-10-S99,
the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the Initial Public Offering and the Over-Allotment, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit. Subsequently, the Company recognized changes in the redemption value as an increase in the redemption value of the Class A ordinary share subject to possible redemption as reflected on the accompanying unaudited condensed consolidated statements of changes in shareholders’ deficit.
Income Taxes
FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman Islands’ federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average of ordinary shares outstanding for the respective period.
 
11
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The calculation of diluted net income does not consider the effect of the Public Warrants and the Private Placement Warrants to purchase an aggregate of 15,558,333 Class A ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares:
 
    
For the Three Months Ended September 30,
     
For the Nine Months Ended September 30,
  
    
2023
     
2022
     
2023
     
2022
  
                                                         
    
Class A
     
Class B
     
Class A
     
Class B
     
Class A
     
Class B
     
Class A
     
Class B
  
                                                         
Basic and diluted net income per ordinary share:
                        
Numerator:
                        
Allocation of net income - basic and diluted
    $ 666,662      $ 166,666      $ 2,409,872      $ 602,468      $ 7,775,670      $ 1,943,918      $ 9,373,599      $ 2,343,400  
Denominator:
                        
Basic and diluted weighted average ordinary shares outstanding
      34,500,000        8,625,000        34,500,000        8,625,000        34,500,000        8,625,000        34,500,000        8,625,000  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income per ordinary share
    $ 0.02      $ 0.02      $ 0.07      $ 0.07      $ 0.23      $ 0.23      $ 0.27      $ 0.27  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
On July 22, 2021, the Company consummated its Initial Public Offering of 30,000,000 Units, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $28.3 million, of which $10.5 million was for deferred underwriting commissions and $11.1 million was the excess of fair value over price paid of Founder Shares sold to the Anchor Investors. On July 23, 2021, the underwriters exercised their over-allotment option in full and on July 27, 2021, they purchased 4,500,000 additional Units, generating gross proceeds of $45.0 million, and incurring offering costs of approximately $2.5 million, of which approximately $1.6 million was for deferred underwriting commissions. Approximately $1.3 million of the offering costs were allocated to derivative warrant liabilities. The Anchor Investors purchased 32,400,000 Units in the Initial Public Offering and the Over-Allotment. None of the Anchor Investors is affiliated with any member of the Company’s management.
Each Unit consists of one Class A ordinary share and
one-fourth
of one Public Warrant. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8).
NOTE 4. RELATED PARTY TRANSACTIONS
Founder Shares
On February 9, 2021, the Sponsor paid $
25,000
, or approximately $
0.003
per share, to cover certain expenses on behalf of the Company in consideration of 7,187,500 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”). On February 18, 2021, the Company issued 1,437,500 Class B ordinary shares in connection with a share capitalization, resulting in an aggregate of 8,625,000 Founder Shares outstanding. The Sponsor agreed to forfeit up to 1,125,000 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On July 27, 2021, the underwriters purchased the Units subject to the over-allotment option in full, and as a result, 1,125,000 Founder Shares were no longer subject to possible forfeiture.
In exchange for the Anchor Investors’ participation in the Initial Public Offering as described in Note 3, the Sponsor sold a total of 1,650,000 Founder Shares to the Anchor Investors. The Company determined that the fair value of these Founder Shares was approximately $11.1 million (or $6.73 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these Founder Shares, over the price paid by the Anchor Investors, as a cost of the Initial Public Offering.
 
12
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The holders of the Founder Shares agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until one year after the completion of a Business Combination or earlier if, subsequent to the Business Combination, (x) the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 120 days after the Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property.
Private Placement Warrants
Simultaneously with the closing of the Initial Public Offering, the Company completed the sale of 6,333,333 Private Placement Warrants in a Private Placement, at a price of $1.50 per Private Placement Warrant, to TortoiseEcofin Borrower, generating proceeds of $9.5 million. Concurrently with the consummation of the Over-Allotment on July 27, 2021, TortoiseEcofin Borrower purchased 600,000 additional Private Placement Warrants, generating proceeds of $900,000. Pursuant to that certain securities purchase agreement, dated as of July 19, 2023, HCGP acquired from TortoiseEcofin Borrower all of its limited liability company interests in the Sponsor, as well as 5,893,333 Private Placement Warrants of the Company held by TortoiseEcofin Borrower.
Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants will be
non-redeemable
for cash and exercisable on a cashless basis so long as they are held by TortoiseEcofin Borrower or its permitted transferees.
HCGP, TortoiseEcofin Borrower, the Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of a Business Combination (see Note 8).
Related Party Loans
On February 3, 2021, the Sponsor agreed to loan the Company an aggregate of up to $600,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was
non-interest
bearing and payable upon the consummation of the Initial Public Offering. The Company borrowed approximately $195,000 under the Note and repaid the Note in full on July 22, 2021 and borrowings thereunder are no longer available.
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination is not completed within the Combination Period, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants.
On February 1, 2023, the Company issued a nonconvertible unsecured promissory note (the “2023 Note”) in the principal amount of $500,000 to TortoiseEcofin Borrower. The 2023 Note is not convertible into equity securities, does not bear interest and is repayable in full upon consummation of a Business Combination. If the Company does not complete a Business Combination, the 2023 Note will not be repaid and all amounts owed under it will be forgiven.
On February 1, 2023, March 9, 2023 and May 9, 2023, the Company borrowed $100,000, $50,000 and $185,000, respectively, under the 2023 Note. As of September 30, 2023 and December 31, 2022, the Company had $335,000 and $0, respectively, outstanding under Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans have not been determined and no written agreements exist with respect to such loans.
On July 19, 2023, The Company issued the HCGP Note in the principal amount of up to $1,000,000 to HCGP. The HCGP Note was issued in connection with advances HCGP may make in the future to the Company for working capital expenses. The HCGP Note bears no interest and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the election of HCGP, all or a portion of the unpaid principal amount of the HCGP Note may be converted into warrants that are identical to the Private Placement Warrants (the “Conversion Warrants”) at a price of $1.50 per warrant. The Conversion Warrants and their underlying securities are entitled to the registration rights set forth in the HCGP Note. On August 7, 2023 and August 18, 2023, the Company borrowed $100,000 and $280,000, respectively, under the HCGP Note. As of September 30, 2023, the Company had $380,000 outstanding under the HCGP Note which is recorded as convertible note – related party on the condensed consolidated balance sheets.
 
13
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Due to Related Party
On July 31, 2023, the Board agreed to pay a quarterly salary of $25,000 to each independent director, and an additional $5,000 to the chair of the audit committee, for services rendered prior to or in connection with the completion of the Business Combination. For the three and nine months ended September 30, 2023, the Company expensed $53,333 for services rendered by the independent directors. At September 30, 2023 and December 31, 2022, the Company had accrued approximately $53,333 and $0, respectively, in compensation expense to the independent directors which are included in due to related party on the condensed consolidated balance sheets.
Administrative Support Agreement
On July 19, 2021, the Company entered into an administrative support agreement (the “Administrative Support Agreement”) with Tortoise Capital Advisors, pursuant to which, commencing on the date that the Company’s securities were first listed on the New York Stock Exchange through the earlier of consummation of a Business Combination and the date of the Company’s liquidation, the Company agreed to pay Tortoise Capital Advisors $10,000 per month for office space, utilities and secretarial and administrative support made available to the Company. As of September 30, 2023 and December 31, 2022, the Company had $50,000 and $0 amounts payable for such services, respectively. On July 19, 2023, HCGP assumed Tortoise Capital Advisors’ rights and obligations under the Administrative Support Agreement. For the three and nine months ended September 30, 2023, the Company incurred $30,000 and $90,000, respectively, for such expenses, included as general and administrative expenses—related party on the accompanying unaudited condensed consolidated financial statements of operations. For the three and nine months ended September 30, 2022, the Company incurred $30,000 and $90,000, respectively, for such expenses, included as general and administrative expenses—related party on the accompanying unaudited condensed consolidated financial statements of operations.
In addition, the Sponsor, the Company’s executive officers and directors, or any of their respective affiliates will be reimbursed for any
out-of-pocket
expenses incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, the Company’s executive officers or directors, or the Company’s or their affiliates. Any such payments prior to a Business Combination will be made using funds held outside the Trust Account. During the three and nine months ended September 30, 2023, the Company incurred approximately $354 and $21,000, respectively, of such expenses. During the three and nine months ended September 30, 2022, the Company incurred approximately $16,000 and $66,000, respectively, of such expenses. Approximately $0 and $1,000 was payable and recorded as accounts payable in the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022, respectively.
NOTE 5. COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares), and any Class A ordinary shares held by the Company’s initial shareholders and HCGP at the completion of the Initial Public Offering or acquired prior to or in connection with a Business Combination, are entitled to registration rights pursuant to a registration rights agreement entered into on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable
lock-up
period, which occurs (i) in the case of the Founder Shares held by the initial shareholders, in accordance with the letter agreement the Company’s initial shareholders entered into, (ii) in the case of the Founder Shares held by the Anchor Investors, in accordance with the investment agreements entered into by and among the Company, the Sponsor and the Anchor Investors and (iii) in the case of the Private Placement Warrants, 30 days after the completion of the Company’s Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
 
14
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
Underwriting Agreement
The Company granted the underwriters a
45-day
option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters purchased the Units subject to the over-allotment option in full on July 27, 2021.
The underwriters were entitled to underwriting commissions of $0.20 per Unit, or $6.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per Unit, or $10.5 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
In connection with the consummation of the Over-Allotment on July 27, 2021, the underwriters were paid an additional fee of $900,000, and approximately $1.6 million in additional deferred underwriting commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
On July 17, 2023, three of the four underwriters for the Company’s Initial Public Offering, consisting of Barclays Capital Inc., Goldman Sachs & Co. LLC and Academy Securities, Inc., agreed to waive all rights to their respective portion of the underwriting commissions (or approximately $9.96 million of the total $12.075 million of the underwriting commissions) with respect to the Company’s proposed Business Combination. As of September 30, 2023, one of the underwriters had further agreed to waive all rights to their respective portion of the underwriting commissions (approximately $4.83 million) with respect to the Company’s proposed Business Combination or to any future Business Combination.
Deferred Legal Fees Associated with the Initial Public Offering and Certain Other Matters
The Company entered into an engagement letter to obtain legal advisory services, pursuant to which the Company’s legal counsel agreed to defer half of their fees associated with the Initial Public Offering until the closing of a Business Combination and has arranged the deferral of certain other legal expenses in connection with the Business Combination. As of September 30, 2023 and December 31, 2022, the Company recorded an aggregate of approximately $518,000 for such deferred legal fees in the accompanying condensed consolidated balance sheets.
Risks and Uncertainties
Various social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide. Specifically, the military conflicts in Ukraine the Middle East, and resulting market volatility could adversely affect the Company’s ability to complete a Business Combination. In response to the conflicts between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a Business Combination and the value of the Company’s securities.
Business Combination with One Energy
Business Combination Agreement
On August 14, 2023, the Company entered into a Business Combination Agreement (the “Business Combination Agreement”) with Merger Sub and One Energy.
Pursuant to the Business Combination Agreement, subject to the terms and conditions set forth therein, (i) the Company will transfer by way of continuation from the Cayman Islands to Delaware and domesticate as a Delaware corporation, (ii) Merger Sub will merge with and into One Energy (the “Merger”), with One Energy as the surviving company in the Merger and, as a result of the Merger, One Energy will become a wholly-owned subsidiary of the Company, and (iii) the Company will be renamed “One Power Company”.
Earn Out Consideration
In addition to the base consideration paid at the closing of the Transactions (the “Closing”), for the period of time from 90 days after the Closing and ending on
the 5-year anniversary
of the Closing (“One Energy Earnout Period”), stockholders of One Energy will have the right to earn additional ordinary shares of the Company upon the following terms:
 
  •  
On the date on which the daily volume-weighted average share price of ordinary shares of the Company (“TRTL VWAP”) is greater than $12.50 for any twenty trading days out of thirty consecutive trading days, a
one-time
issuance of 2,500,000 ordinary shares of the Company; and
 
  •  
On the date on which the TRTL VWAP is greater than $15.00 for any twenty trading days out of thirty consecutive trading days, a
one-time
issuance of 2,500,000 ordinary shares of the Company.
 
15
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
If, during the One Energy Earnout Period there is a change of control transaction in which the Company or its shareholders have the right to receive consideration implying a value per share (as agreed in good faith by the Board) that is greater than or equal to the applicable TRTL VWAP prices specified above, any applicable earnout shares that have not previously been issued will be issued to the One Energy stockholders.
Sponsor Support Agreement
In connection with the execution of the Business Combination Agreement, the Sponsor entered into a sponsor support agreement (the “Sponsor Support Agreement”) with the Company and One Energy, pursuant to which the Sponsor and each of the Company shareholders party thereto agreed to (a) vote in favor of the Business Combination Agreement and the Transactions, (b) not transfer their shares of the Company during the period between the signing of the Business Combination Agreement and the Closing, (c) waive any adjustment to the conversion ratio set forth in the governing documents of the Company or any other anti-dilution or similar protection with respect to their shares of the Company, and (d) subject 2,250,000 of their shares of the Company to potential vesting and forfeiture based on a stock price based earnout over a
two-year
period, with an early release if the TRTL VWAP exceeds $12.00 per share over 20 out of any 30 consecutive trading days, during such
two-year
period after Closing.
Transaction Support Agreement
In connection with the execution of the Business Combination Agreement, Jereme Kent, CAS Ohio LLC and RES Ohio LLC (collectively, the “Supporting Company Stockholders”) entered into a transaction support agreement (the “Transaction Support Agreement”), pursuant to which, among other things, each such Supporting Company Stockholder agreed to, (a) support and vote in favor of the Business Combination Agreement and the ancillary documents to which One Energy is or will be a party and the Transactions, (b) not transfer their One Energy shares during the interim period prior to the Closing, and (c) take, or cause to be taken, any actions necessary or advisable to cause certain agreements to be terminated effective as of the Closing.
Registration Rights Agreement
Prior to the Closing, the Sponsor and certain One Energy stockholders will enter into an amended and restated registration rights agreement (the “Registration Rights Agreement”). Under the Registration Rights Agreement, the Sponsor and certain other shareholders of the Company and certain One Energy stockholders shall have registration rights that will obligate the Company to register for resale under the Securities Act all or any portion of the (i) ordinary shares of the Company issued to the One Energy stockholders as Transaction Consideration Shares, (ii) the ordinary shares of the Company held by the Sponsor and other legacy shareholders of the Company, (iii) the ordinary shares of the Company issued upon conversion of the ordinary shares of the Company in connection with the Merger, and (iv) the ordinary shares of the Company issuable upon exercise of all warrants held by the Company shareholders (together with any capital shares or other securities issued as a dividend or distribution with respect thereto or in exchange therefor, the “Registrable Securities”). Pursuant to the Registration Rights Agreement, among other things, the Company shall prepare and file a shelf resale registration statement with respect to the registrable securities under the Registration Rights Agreement no later than 60 calendar days prior to the expiration of the applicable post-Closing
lock-up
period. The Company shareholders who hold a majority in interest of the Registrable Securities held by the legacy shareholders of the Company or One Energy stockholders who hold a majority in interest of the Registrable securities held by the legacy One Energy stockholders, will be entitled under the Registration Rights Agreement to make a written demand for registration under the Securities Act of all or part of their Registrable Securities. Subject to certain exceptions, if any time after the Closing, the Company proposes to file a registration statement under the Securities Act with respect to its securities, under the Registration Rights Agreement, the Company shall give notice to the Company shareholders holding Registrable Securities and the One Energy stockholders holding Registrable Securities, as to the proposed filing and offer them an opportunity to register the sale of such number of Registrable Securities as requested by them in writing, subject to customary
cut-backs.
In addition, subject to certain exceptions, the Company shareholders and the One Energy stockholders holding Registrable Securities will be entitled under the Registration Rights Agreement to request in writing that the Company register the resale of any or all of such Registrable Securities on Form
S-3
or
F-3
and any similar short-form registration that may be available at such time. Under the Registration Rights Agreement, the Company will indemnify the holders of Registrable Securities and certain persons or entities related to them, such as their officers, directors, employees, agents and representatives, against any losses or damages resulting from any untrue statement or omission of a material fact in any registration statement or prospectus pursuant to which they sell Registrable Securities, unless such liability arose from their misstatement or omission, and the holders of Registrable Securities, including Registrable Securities in any registration statement or prospectus, will agree to indemnify the Company and certain persons or entities related to the Company, such as its officers and directors and underwriters, against all losses caused by their misstatements or omissions in those documents.
Contingent Stock Rights Agreement
Prior to or in connection with the Closing, the Company, the Sponsor, Jereme Kent and Continental Stock Transfer & Trust Company will enter into a contingent stock rights agreement, pursuant to which Jereme Kent will deposit 5.5 million of the shares of the Company he will receive as consideration in the Transactions into an escrow account to provide certain contingent stock rights to PIPE investors and/or to public shareholders of the Company who do not redeem their shares of the Company in connection with the Transactions, in the event that the post-closing trading price of the combined public company does not equal or exceed a daily VWAP of $12.00 per share over 20 out of any 30 consecutive trading days, during the
two-year
period after Closing.
 
16
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
NOTE 6. CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION
The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 220,000,000 ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of September 30, 2023 and December 31, 2022, there were 34,500,000 Class A ordinary shares outstanding, all of which were subject to possible redemption.
Class A ordinary shares subject to possible redemption reflected on the condensed consolidated balance sheets is reconciled on the following table:
 
Gross proceeds
    $ 345,000,000  
Less:
   
Proceeds allocated to public warrants
      (14,662,500 ) 
Class A ordinary share issuance costs
      (29,430,786 ) 
Plus:
   
Increase in redemption value of Class A ordinary shares subject to possible redemption
      48,984,439  
  
 
 
  
Class A ordinary share subject to possible redemption, December 31, 2022
   
 
349,891,153
 
Plus:
   
Gain on waiver of deferred underwriting fees
      4,624,725  
Increase in redemption value of Class A ordinary shares subject to possible redemption
      6,733,317  
  
 
 
  
Class A ordinary share subject to possible redemption, September 30, 2023
   
$
361,249,195
 
  
 
 
  
 
17
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
NOTE 7. SHAREHOLDERS’ DEFICIT
Preference Shares
- The Company is authorized to issue 1,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Board. As of September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares
- The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were 34,500,000 Class A ordinary shares issued and outstanding, all subject to possible redemption and therefore classified as temporary equity (see Note 6). In connection with the Extension Meeting, shareholders holding 17,235,298 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account.
Class
 B Ordinary Shares
- The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. In February 2021, the Company issued 7,187,500 Class B ordinary shares to the Sponsor in exchange for the payment of $25,000, or approximately $0.003 per share. On February 18, 2021, the Company issued 1,437,500 Class B ordinary shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Founder Shares. All shares and associated amounts have been retroactively adjusted to reflect the share capitalization. Of the 8,625,000 Class B ordinary shares, an aggregate of up to 1,125,000 shares were subject to forfeiture to the Company by the Sponsor for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that holders of the Founder Shares would collectively own 20% of the Company’s issued and outstanding ordinary shares. The underwriters purchased the units subject to the over-allotment option in full on July 27, 2021; therefore, these 1,125,000 Class B ordinary shares were no longer subject to possible forfeiture. As a result, as of September 30, 2023 and December 31, 2022, there were 8,625,000 Class B ordinary shares outstanding and none subject to forfeiture.
Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders, except that in respect of any vote or votes to continue the Company in a jurisdiction outside the Cayman Islands (including, but not limited to, the approval of the organizational documents of the Company in such other jurisdiction), holders of Class B ordinary shares will have ten votes per share and holders of Class A ordinary shares will have one vote per share, and except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the election of the Company’s directors (and may also remove a member of the Board for any reason) prior to a Business Combination.
The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a
one-for-one
basis, subject to adjustment for share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of the total number of all ordinary shares outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination). In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than
one-to-one.
 
18
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
NOTE 8. DERIVATIVE WARRANT LIABILITIES
As of September 30, 2023 and December 31, 2022, 8,625,000 Public Warrants and 6,933,333 Private Placement Warrants were outstanding.
The Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination; provided that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company registered the Class A ordinary shares issuable upon exercise of the warrants and agreed to use commercially reasonable efforts to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the board and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Newly Issued Price.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be
non-redeemable
so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the initial shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash (except as described herein with respect to the Private Placement Warrants):
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption; and
 
  •  
if, and only if, the last sale price of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
 
19
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The Company will not redeem the warrants for cash unless a registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the
30-day
redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act.
Commencing 90 days after the warrants become exercisable, the Company may redeem the outstanding warrants for Class A ordinary shares:
 
  •  
in whole and not in part;
 
  •  
at a price equal to a number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption; and
 
  •  
if, and only if, the last sale price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted per share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
The “fair market value” of Class A ordinary shares shall mean the average reported last sale price of Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.
In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
NOTE 9. FAIR VALUE MEASUREMENTS
The following tables presents information about the Company’s assets and liabilities as of September 30, 2023 and December 31, 2022, that are measured at fair value on a recurring basis, by level within the fair value hierarchy:
September 30, 2023
 
Description
   
Quoted
Prices in
Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Liabilities:
         
Derivative warrant liabilities - Public Warrants
    $  1,466,250      $ —        $ —    
Derivative warrant liabilities - Private Placement Warrants
    $ —        $ 1,178,667      $ —    
December 31, 2022
 
Description
   
Quoted
Prices in
Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Assets:
         
Investments and cash held in Trust Account
    $ 349,991,153      $ —        $ —    
Liabilities:
         
Derivative warrant liabilities - Public Warrants
    $ 1,725,000      $ —        $ —    
Derivative warrant liabilities - Private Placement Warrants
    $ —        $ 1,386,667      $ —    
Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of Public Warrants was transferred from a Level 1 measurement to a Level 2 measurement due to lack of trading activity as of September 30, 2023 and 2022. As of September 30, 2023 and 2022, the estimated fair value of the Public Warrants was transferred back to a Level 1 measurement due to adequate trading activity.
 
20
TORTOISEECOFIN ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
The Public Warrants issued in connection with the Initial Public Offering and the Over-Allotment, and the Private Placement Warrants sold in the Private Placement and the Second Private Placement were initially measured at fair value using a Black-Scholes option pricing model and a Monte Carlo simulation, respectively. For periods subsequent to the detachment of the Public Warrants from the Units, the fair value of the Public Warrants is based on the observable listed price for such warrants, and the fair value of the warrants issued in the Private Placement and the Second Private Placement was estimated by reference to the listed market price of the Public Warrants.
For the three and nine months ended September 30, 2023, the Company recognized a loss and gain resulting from an increase and decrease in fair value of the derivative warrant liabilities of approximately $1.9 million and $467,000, respectively, presented as change in fair value of derivative warrant liabilities in the accompanying unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2022, the Company recognized a gain resulting from a decrease in the fair value of the derivative warrant liabilities of approximately $1.9 million and $11 million, respectively, presented as change in the fair value of derivative warrant liabilities in the accompanying unaudited condensed consolidated statements of operations.
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed consolidated financial statements were issued. Based on this review, besides the below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements, other than as described below.
On October 19, 2023, the Company held the Extension Meeting. At the Extension Meeting, the shareholders of the Company approved, among other things, a proposal to amend by special resolution the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate an initial Business Combination from October 22, 2023 on a monthly basis up to six times until April 22, 2024 (or such earlier date as determined by the Board in its sole discretion). Shareholders holding 17,235,298 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $180.9 million (approximately $10.49 per share) was removed from the Trust Account to pay such holders.
On October 20, 2023, the Company issued a promissory note (the “Extension Note”) in the aggregate principal amount of up to $1,553,823.18 (“Extension Funds”) to the Sponsor, pursuant to which the Extension Funds will be deposited into the Company’s Trust Account for the benefit of each outstanding Public Share that was not redeemed in connection with the Meeting. The Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of the Company’s initial Business Combination, and (b) the date of the liquidation of the Company.
The Company will deposit $258,970.53 per month into the Trust Account, which equates to $0.015 per remaining Public Share, for each calendar month (commencing on October 23, 2023 and on the 23rd day of each subsequent month) until April 22, 2024, or portion thereof, that is needed to complete an initial Business Combination, for up to an aggregate of $1,553,823.18.
 
21

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “our,” “us” or “we” refer to TortoiseEcofin Acquisition Corp. III. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other U.S. Securities and Exchange Commission (the “SEC”) filings.

Overview

We are a blank check company incorporated as a Cayman Islands exempted company on February 3, 2021. We were incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities that we have not yet identified.

Our sponsor is TortoiseEcofin Sponsor III LLC, a Cayman Islands limited liability company (the “Sponsor”), which is owned by Hennessy Capital Growth Partners Fund I SPV V, LLC, a Delaware limited liability company (“HCGP”), and its consolidated subsidiaries and our management (directly or indirectly, including through family trusts). On February 9, 2021, the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain expenses on behalf of the Company in consideration of 7,187,500 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”). The registration statement for our initial public offering (the “Initial Public Offering”) was declared effective by the SEC on July 19, 2021. On July 22, 2021, we consummated our Initial Public Offering of 30,000,000 units (the “Units”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $28.3 million, of which $10.5 million was for deferred underwriting commissions and $11.1 million was the excess of the fair value of the Founder Shares sold by the Sponsor to certain qualified institutional buyers or institutional accredited investors (the “Anchor Investors”) over the price paid by such Anchor Investors for such Founder Shares. On July 23, 2021, the underwriters exercised their over-allotment option in full and on July 27, 2021, they purchased 4,500,000 additional Units, generating gross proceeds of $45.0 million (the “Over-Allotment”), and incurring offering costs of approximately $2.5 million, of which approximately $1.6 million was for deferred underwriting commissions. Approximately $1,329,000 of the offering costs were allocated to derivative warrant liabilities.

Simultaneously with the closing of our Initial Public Offering, we completed the sale of 6,333,333 warrants (the “Private Placement Warrants”) in a private placement (the “Private Placement”), at a price of $1.50 per Private Placement Warrant, to TortoiseEcofin Borrower LLC, a Delaware limited liability company (“TortoiseEcofin Borrower”), generating proceeds of $9.5 million. Concurrently with the consummation of the Over-Allotment on July 27, 2021, TortoiseEcofin Borrower purchased 600,000 additional Private Placement Warrants, generating proceeds of $900,000 (the “Second Private Placement”). Pursuant to that certain securities purchase agreement, dated as of July 19, 2023, HCGP acquired from TortoiseEcofin Borrower all of its limited liability company interests in the Sponsor, as well as 5,893,333 Private Placement Warrants of the Company held by TortoiseEcofin Borrower.

 

22

Upon the closing of the Initial Public Offering and the Private Placement on July 22, 2021, and the closing of the Over-Allotment and the Second Private Placement on July 27, 2021, the net proceeds thereof consisting of $345.0 million ($10.00 per Unit) were placed in a trust account (the “Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and may be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by us, until the earlier of: (i) the completion of an initial business combination and (ii) the distribution of the Trust Account as described below.

Our management has broad discretion with respect to the specific application of the net proceeds of our Initial Public Offering, the Over-Allotment and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating an initial business combination. If we have not completed an business combination by November 22, 2023, or a later date if extended (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses and net of taxes payable), divided by the number of then outstanding public shares, which redemption will completely extinguish our public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

Liquidity and Capital Resources

As of September 30, 2023, we had approximately $13,000 in operating cash and a working capital deficit of approximately $1,192,000.

Our liquidity needs prior to the consummation of our Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover certain expenses on behalf of our Company in exchange for the issuance of 8,625,000 Founder Shares, and the loan from our Sponsor of approximately $195,000 under an unsecured promissory note (the “Note”). We repaid the Note in full on July 22, 2021 and borrowings thereunder are no longer available. Subsequent to the consummation of the Initial Public Offering, our liquidity has been satisfied through the net proceeds of $3.5 million from the consummation of the Initial Public Offering, the Over-Allotment and the sale of the Private Placement Warrants held outside of the Trust Account. In addition, in order to finance general working capital needs in connection with an initial business combination, our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors may, but are not obligated to, provide us with funds as may be required (“Working Capital Loans”). On February 1, 2023, we issued the 2023 Note to TortoiseEcofin Borrower in the amount of $500,000 to finance our general working capital needs. On February 1, 2023, March 9, 2023 and May 9, 2023, the Company borrowed a $100,000, $50,000 and $185,000, respectively, under the 2023 Note. As of September 30, 2023 and December 31, 2022, there were $335,000 and $0, respectively, outstanding under Working Capital Loans. On July 19, 2023, the Company issued a promissory note (the “HCGP Note”) in the principal amount of up to $1,000,000 to HCGP. The HCGP Note was issued in connection with advances HCGP may make in the future to the Company for working capital expenses. The HCGP Note bears no interest and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the election of HCGP, all or a portion of the unpaid principal amount of the HCGP Note may be converted into warrants of the Company at a price of $1.50 per warrant (the “Conversion Warrants”). The Conversion Warrants and their underlying securities are entitled to the registration rights set forth in the HCGP Note. On August 7, 2023 and August 18, 2023, the Company borrowed $100,000 and $280,000, respectively, under the HCGP Note.

In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements-Going Concern,” management has determined that liquidity condition and mandatory liquidation and subsequent dissolution raise substantial doubt about its ability to continue as a going concern. We intend to complete an initial business combination before the mandatory liquidation date; however, there can be no assurance that we will be able to consummate any business combination within the Combination Period. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after the Combination Period. The condensed consolidated interim financial statements do not include any adjustment that might be necessary if we are unable to continue as a going concern.

 

23

Results of Operations

Our entire activity from February 3, 2021 (inception) through July 22, 2021 was in preparation for an Initial Public Offering, and since the completion of our Initial Public Offering through September 30, 2023, our activity had been limited to the searching, negotiation and completing an initial business combination. We will not generate any operating revenues until the closing and completion of our initial business combination.

For the three months ended September 30, 2023, we had net income of approximately $0.8 million, which consisted of approximately $3.8 million in interest income from cash held in the Trust Account and other income attributable to derecognition of deferred underwriting fee allocated to offering costs of $205,000, partly offset by approximately $1.9 million in change in fair value of derivative warrant liabilities and approximately $1,231,000 of general and administrative expenses inclusive of $30,000 of administrative expenses with a related party.

For the three months ended September 30, 2022, we had net income of approximately $3.0 million, which consisted of approximately $1.9 million in change in fair value of derivative warrant liabilities and approximately $1.6 million in interest income from cash and investments held in the Trust Account, partly offset by approximately $412,000 of general and administrative expenses inclusive of $30,000 of administrative expenses with a related party.

For the nine months ended September 30, 2023, we had net income of approximately $9.7 million, which consisted of approximately $11.4 million in interest income from cash held in the Trust Account, approximately $467,000 in change in fair value of derivative warrant liabilities and other income attributable to derecognition of deferred underwriting fee allocated to offering costs of $205,000, partly offset by approximately $2.2 million of general and administrative expenses inclusive of $90,000 of administrative expenses with a related party.

For the nine months ended September 30, 2022, we had net income of approximately $11.7 million, which consisted of approximately $11.0 million in change in fair value of derivative warrant liabilities and approximately $2.1 million in interest income from cash and investments held in the Trust Account, partly offset by approximately $1.4 million of general and administrative expenses inclusive of $90,000 of administrative expenses with a related party.

Contractual Obligations

Registration and Shareholder Rights

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters were paid an underwriting discount of $0.20 per Unit, or approximately $6.0 million in the aggregate, upon the closing of our Initial Public Offering. In addition, $0.35 per Unit, or approximately $10.5 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions from the amounts held in the Trust Account solely in the event that that we complete an initial business combination, subject to the terms of the underwriting agreement.

We granted the underwriters a 45-day option from the date of our Initial Public Offering to purchase up to 4,500,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters exercised their over-allotment option in full on July 23, 2021, and on July 27, 2021, the underwriters purchased 4,500,000 additional Units, generating gross proceeds of $45.0 million.

 

24

Upon the consummation of the Over-Allotment on July 27, 2021, the underwriters were paid an additional underwriting commission of $900,000 and approximately $1.6 million in additional deferred underwriting commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete an initial business combination, subject to the terms of the underwriting agreement.

On July 17, 2023, three of the four underwriters for the Company’s Initial Public Offering, consisting of Barclays Capital Inc., Goldman Sachs & Co. LLC and Academy Securities, Inc., agreed to waive all rights to their respective portion of the underwriting commissions (or approximately $9.96 million of the total $12.075 million of the underwriting commissions) with respect to the Company’s proposed business combination. As of September 30, 2023, one of the underwriters had further agreed to waive all rights to their respective portion of the underwriting commissions (approximately $4.83 million) with respect to the Company’s proposed business combination or to any future business combination.

Deferred Legal Fees Associated with Initial Public Offering and Certain Other Matters

We entered into an engagement letter to obtain legal advisory services in connection with our Initial Public Offering, pursuant to which our legal counsel agreed to defer half of their fees associated with the Initial Public Offering until the closing of our initial business combination and has arranged the deferral of certain other legal expenses. As of September 30, 2023 and December 31, 2022, we recorded an aggregate of $518,000 for such deferred legal fees in the accompanying balance sheets.

Administrative Support Agreement

On July 19, 2021, the Company entered into an administrative support agreement (the “Administrative Support Agreement”) with Tortoise Capital Advisors, L.L.C. (“Tortoise Capital Advisors”), pursuant to which, commencing on the date that the Company’s securities were first listed on the New York Stock Exchange through the earlier of consummation of a business combination and the date of the Company’s liquidation, the Company agreed to pay Tortoise Capital Advisors $10,000 per month for office space, utilities and secretarial and administrative support made available to the Company. For the three and nine months ended September 30, 2023, the Company incurred $30,000 and $90,000, respectively, for such expenses, included as general and administrative expenses—related party on the accompanying unaudited condensed consolidated financial statements of operations. For the three and nine months ended September 30, 2022, the Company incurred $30,000 and $90,000, respectively, for such expenses, included as general and administrative expenses—related party on the accompanying unaudited condensed consolidated financial statements of operations. As of September 30, 2023 and December 31, 2022, the Company had $50,000 and $0 amounts payable for such services. On July 19, 2023, HCGP assumed Tortoise Capital Advisors’ rights and obligations under the Administrative Support Agreement.

In addition, the Sponsor, the Company’s executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable business combination targets. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, the Company’s executive officers or directors, or the Company’s or their affiliates. Any such payments prior to an initial business combination will be made using funds held outside the Trust Account. During the three and nine months ended September 30, 2023, the Company incurred $354 and $21,000, respectively, of such expenses. During the three and nine months ended September 30, 2022, the Company incurred $16,000 and $66,000, respectively, of such expenses. Approximately $28 and $1,000 was payable as of September 30, 2023 and December 31, 2022, respectively.

Critical Accounting Estimates

The preparation of unaudited condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of income and expenses during the period reported. Actual results could materially differ from those estimates. We have not identified any critical accounting estimates. 

 

25

Off-Balance Sheet Arrangements

As of September 30, 2023, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.

JOBS Act

The Jumpstart Our Business Startups Act of 2021 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and, under the JOBS Act, are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our unaudited condensed consolidated financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (a) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the JOBS Act, (b) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (c) comply with any requirement that may be adopted by the Public Company Accounting and Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (d) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of our Chief Executive Officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2023, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were not effective as of September 30, 2023 due to the accounting of waiving the deferred underwriting fees.

As a result, our management performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with generally accepted principles in the United States of America. Accordingly, management believes that the financial statements included in this Quarterly Report present fairly, in all material respects, the Company’s financial position, result of operations and cash flows of the periods presented.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

26

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

 

Exhibit
Number		   

Description

    2.1    Business Combination Agreement, dated as of August 14, 2023, by and among TortoiseEcofin Acquisition Corp. III, One Energy Enterprises Inc. and TRTL III Merger Sub Inc. (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K, filed with the SEC on August 18, 2023)
  10.1    Sponsor Support Agreement, dated as of August 14, 2023, by and among TortoiseEcofin Acquisition Corp., One Energy Enterprises Inc. and TortoiseEcofin Sponsor III LLC (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed with the SEC on August 18, 2023)
  10.2    Transaction Support Agreement, dated as of August 14, 2023, by and among TortoiseEcofin Acquisition Corp., One Energy Enterprises Inc. and certain Supporting Company Stockholders (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K, filed with the SEC on August 18, 2023)
  10.3    Form of Registration Rights Agreement by and among TortoiseEcofin Sponsor III LLC and certain One Energy stockholders (incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K, filed with the SEC on August 18, 2023)
  10.4    Form of Contingent Stock Rights Agreement, by and among TortoiseEcofin Sponsor III LLC, Jereme Kent and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K, filed with the SEC on August 18, 2023)
  31.1    Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2    Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32.1*    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  32.2*    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS    Inline XBRL Instance Document.
101.SCH    Inline XBRL Taxonomy Extension Schema Document.
101.CAL    Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB    Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

27

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereto duly authorized.

 

    TORTOISEECOFIN ACQUISITION CORP. III
Date: November 14, 2023    

/s/ Vincent T. Cubbage

      Name:   Vincent T. Cubbage
      Title:   Chief Executive Officer
        (Principal Executive Officer)
Date: November 14, 2023    

/s/ Stephen Pang

      Name:   Stephen Pang
      Title:   President and Chief Financial Officer
        (Principal Financial Officer and Principal Accounting Officer)

 

28

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Vincent T. Cubbage, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 of TortoiseEcofin Acquisition Corp. III (the “registrant”);

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2023      

/s/ Vincent T. Cubbage

      Vincent T. Cubbage
      Chief Executive Officer
      (Principal Executive Officer)

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Stephen Pang, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 of TortoiseEcofin Acquisition Corp. III (the “registrant”);

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2023      

/s/ Stephen Pang

      Stephen Pang
      President and Chief Financial Officer
      (Principal Financial Officer)

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of TortoiseEcofin Acquisition Corp. III (the “Company”) for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Vincent T. Cubbage, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

  (1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14, 2023    

/s/ Vincent T. Cubbage

    Name:   Vincent T. Cubbage
    Title:   Chief Executive Officer
(Principal Executive Officer)

 

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of TortoiseEcofin Acquisition Corp. III (the “Company”) for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen Pang, President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

  (1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14, 2023    

/s/ Stephen Pang

    Name:   Stephen Pang
    Title:   President and Chief Financial Officer
(Principal Financial Officer)
v3.23.3
Cover Page - shares
 9 Months Ended
Sep. 30, 2023
Nov. 13, 2023
Document Information [Line Items]    
Entity Registrant Name TORTOISEECOFIN ACQUISITION CORP. III  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Entity Central Index Key 0001847112  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company true  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity Incorporation, State or Country Code E9  
Entity File Number 001-40633  
Entity Tax Identification Number 98-1583266  
Entity Address, Address Line One 195 US HWY 50  
Entity Address, Address Line Two Suite 208  
Entity Address, City or Town Zephyr Cove  
Entity Address, State or Province NV  
Entity Address, Postal Zip Code 89448  
City Area Code (913)  
Local Phone Number 981-1020  
Entity Interactive Data Current Yes  
Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-fourth of one redeemable warrant [Member]    
Document Information [Line Items]    
Trading Symbol TRTL.U  
Title of 12(b) Security Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-fourth of one redeemable warrant  
Security Exchange Name NYSE  
Class A Ordinary Shares included as part of the units [Member]    
Document Information [Line Items]    
Trading Symbol TRTL  
Title of 12(b) Security Class A Ordinary Shares included as part of the units  
Security Exchange Name NYSE  
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 [Member]    
Document Information [Line Items]    
Trading Symbol TRTL WS  
Title of 12(b) Security Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50  
Security Exchange Name NYSE  
Class A Ordinary Shares [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   17,264,702
Class B Ordinary Shares [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   8,625,000
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 13,137 $ 78,997
Prepaid expenses 193,312 421,809
Total current assets 206,449 500,806
Cash and investments held in Trust Account 361,349,195 349,991,153
Total Assets 361,555,644 350,491,959
Current liabilities:    
Accounts payable 834,481 30,076
Accrued expenses 564,344 120,960
Total current liabilities 1,398,825 151,036
Promissory note – related party 335,000
Convertible promissory note 380,000
Due to related party $ 53,333
Other Liability, Noncurrent, Related Party, Type [Extensible Enumeration] Related Party [Member] Related Party [Member]
Deferred legal fees $ 173,667 $ 173,667
Deferred underwriting commissions 7,245,000 12,075,000
Derivative warrant liabilities 2,644,917 3,111,667
Total Liabilities 12,230,742 15,511,370
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 34,500,000 shares issued and outstanding at approximately $10.47 and $10.14 at September 30, 2023 and December 31, 2022, respectively 361,249,195 349,891,153
Shareholders' Deficit    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at September 30, 2023 and December 31, 2022
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no non-redeemable shares issued or outstanding at September 30, 2023 and December 31, 2022
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding at September 30, 2023 and December 31, 2022 863 863
Accumulated deficit (11,925,156) (14,911,427)
Total shareholders' deficit (11,924,293) (14,910,564)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit $ 361,555,644 $ 350,491,959
v3.23.3
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A Ordinary Shares [Member]    
Ordinary shares subject to possible redemption, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares subject to possible redemption, shares issued 34,500,000 34,500,000
Ordinary shares subject to possible redemption, shares outstanding 34,500,000 34,500,000
Ordinary shares subject to possible redemption value (in Dollars per share) $ 10.47 $ 10.14
Ordinary shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, shares authorized 200,000,000 200,000,000
Ordinary shares, shares issued
Ordinary shares, shares outstanding
Class B Ordinary Shares [Member]    
Ordinary shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, shares authorized 20,000,000 20,000,000
Ordinary shares, shares issued 8,625,000 8,625,000
Ordinary shares, shares outstanding 8,625,000 8,625,000
v3.23.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Administrative expenses – related party $ 30,000 $ 30,000 $ 90,000 $ 90,000
General and administrative expenses 1,231,170 381,915 2,220,479 1,312,022
Loss from operations (1,261,170) (411,915) (2,310,479) (1,402,022)
Other income:        
Change in fair value of derivative warrant liabilities (1,927,677) 1,867,000 466,750 11,046,416
Other income attributable to derecognition of deferred underwriting fee allocated to offering costs 205,275 205,275
Interest income from cash and investments held in Trust Account 3,816,900 1,557,255 11,358,042 2,072,605
Total other income 2,094,498 3,424,255 12,030,067 13,119,021
Net income $ 833,328 $ 3,012,340 $ 9,719,588 $ 11,716,999
Class A Ordinary Shares [Member]        
Other income:        
Weighted average number of ordinary shares - basic 34,500,000 34,500,000 34,500,000 34,500,000
Weighted average number of ordinary shares - diluted 34,500,000 34,500,000 34,500,000 34,500,000
Basic net income per ordinary share $ 0.02 $ 0.07 $ 0.23 $ 0.27
Diluted net income per ordinary share $ 0.02 $ 0.07 $ 0.23 $ 0.27
Class B Ordinary Shares [Member]        
Other income:        
Weighted average number of ordinary shares - basic 8,625,000 8,625,000 8,625,000 8,625,000
Weighted average number of ordinary shares - diluted 8,625,000 8,625,000 8,625,000 8,625,000
Basic net income per ordinary share $ 0.02 $ 0.07 $ 0.23 $ 0.27
Diluted net income per ordinary share $ 0.02 $ 0.07 $ 0.23 $ 0.27
v3.23.3
Unaudited Condensed Consolidated Statements Of Operations (Parentheticals) - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A Ordinary Shares [Member]        
Weighted average ordinary shares Diluted 34,500,000 34,500,000 34,500,000 34,500,000
Diluted net income per share $ 0.02 $ 0.07 $ 0.23 $ 0.27
Class B Ordinary Shares [Member]        
Weighted average ordinary shares Diluted 8,625,000 8,625,000 8,625,000 8,625,000
Diluted net income per share $ 0.02 $ 0.07 $ 0.23 $ 0.27
v3.23.3
Unaudited Condensed Consolidated Statements Of Changes In Shareholders' Deficit - USD ($)
Total
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Class A [Member]
Class A [Member]
Ordinary Shares [Member]
Class B [Member]
Ordinary Shares [Member]
Balance at Dec. 31, 2021 $ (24,239,133) $ (24,239,996)   $ 863
Balance (in Shares) at Dec. 31, 2021         8,625,000
Net income 5,811,814 5,811,814  
Balance at Mar. 31, 2022 (18,427,319) (18,428,182)   $ 863
Balance (in Shares) at Mar. 31, 2022         8,625,000
Balance at Dec. 31, 2021 (24,239,133) (24,239,996)   $ 863
Balance (in Shares) at Dec. 31, 2021         8,625,000
Net income 11,716,999          
Balance at Sep. 30, 2022 (14,494,739) (14,495,602)   $ 863
Balance (in Shares) at Sep. 30, 2022         8,625,000
Balance at Mar. 31, 2022 (18,427,319) (18,428,182)   $ 863
Balance (in Shares) at Mar. 31, 2022         8,625,000
Increase in redemption value of Class A ordinary shares subject to possible redemption (415,350) (415,350)  
Net income 2,892,845 2,892,845  
Balance at Jun. 30, 2022 (15,949,824) (15,950,687)   $ 863
Balance (in Shares) at Jun. 30, 2022         8,625,000
Increase in redemption value of Class A ordinary shares subject to possible redemption (1,557,255) (1,557,255)  
Net income 3,012,340 3,012,340  
Balance at Sep. 30, 2022 (14,494,739) (14,495,602)   $ 863
Balance (in Shares) at Sep. 30, 2022         8,625,000
Balance at Dec. 31, 2022 (14,910,564) (14,911,427)   $ 863
Balance (in Shares) at Dec. 31, 2022       34,500,000 8,625,000
Increase in redemption value of Class A ordinary shares subject to possible redemption (3,713,581) (3,713,581)  
Net income 4,910,691 4,910,691  
Balance at Mar. 31, 2023 (13,713,454) (13,714,317)   $ 863
Balance (in Shares) at Mar. 31, 2023         8,625,000
Balance at Dec. 31, 2022 (14,910,564) (14,911,427)   $ 863
Balance (in Shares) at Dec. 31, 2022       34,500,000 8,625,000
Net income 9,719,588          
Balance at Sep. 30, 2023 (11,924,293) (11,925,156)   $ 863
Balance (in Shares) at Sep. 30, 2023       34,500,000 8,625,000
Balance at Mar. 31, 2023 (13,713,454) (13,714,317)   $ 863
Balance (in Shares) at Mar. 31, 2023         8,625,000
Increase in redemption value of Class A ordinary shares subject to possible redemption (3,827,561) (3,827,561)  
Net income 3,975,569 3,975,569  
Balance at Jun. 30, 2023 (13,565,446) (13,566,309)   $ 863
Balance (in Shares) at Jun. 30, 2023         8,625,000
Increase in redemption value of Class A ordinary shares subject to possible redemption 807,825 807,825  
Net income 833,328 833,328  
Balance at Sep. 30, 2023 $ (11,924,293) $ (11,925,156)   $ 863
Balance (in Shares) at Sep. 30, 2023       34,500,000 8,625,000
v3.23.3
Unaudited Condensed Consolidated Statements Of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net income $ 9,719,588 $ 11,716,999
Adjustments to reconcile net income to net cash used in operating activities:    
Change in fair value of derivative warrant liabilities (466,750) (11,046,416)
Other income attributable to derecognition of deferred underwriting fee allocated to offering costs (205,275)  
Interest income from cash and investments held in Trust Account (11,358,042) (2,072,605)
Changes in operating assets and liabilities:    
Prepaid expenses 228,497 547,594
Due to related party 53,333
Accounts payable 804,405 10,887
Accrued expenses 443,384 (2,467)
Net cash used in operating activities (780,860) (846,008)
Cash Flows from Financing Activities:    
Proceeds from convertible note payable to related parties 380,000
Proceeds from promissory note- related party 335,000
Net cash provided by operating activities 715,000
Net change in cash (65,860) (846,008)
Cash – beginning of the period 78,997 1,174,867
Cash – end of the period $ 13,137 $ 328,859
v3.23.3
Description of Organization, Business Operations and Basis of Presentation
 9 Months Ended
Sep. 30, 2023
Description of Organization, Business Operations and Basis of Presentation [Abstract]  
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION
NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION
TortoiseEcofin Acquisition Corp. III (the “Company”) was incorporated as a Cayman Islands exempted company on February 3, 2021. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
The Company has one wholly-owned subsidiary, TRTL III Merger Sub Inc., a Delaware corporation (“Merger Sub”), which was formed for the sole purpose of the consummation of a potential business combination (the “Transactions”) between the Company and One Energy Enterprises Inc., a Delaware corporation (“One Energy”) (see Note 5).
All activity for the period from February 3, 2021 (inception) through September 30, 2023 relates to the Company’s formation and its initial public offering (the “Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, the search for a prospective acquisition for an initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company may generate
non-operating
income in the form of interest income on cash and investments held in trust from the proceeds of its Initial Public Offering. The Company’s fiscal year end is December 31.
The Company’s sponsor is TortoiseEcofin Sponsor III LLC, a Cayman Islands limited liability company (the “Sponsor”), which is owned by Hennessy Capital Growth Partners Fund I SPV V, LLC, a Delaware limited liability company (“HCGP”), and the Company’s management (directly or indirectly, including through family trusts). The registration statement for the Company’s Initial Public Offering was declared effective on July 19, 2021. On July 22, 2021, the Company consummated its Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $28.3 million, of which $10.5 million was for deferred underwriting commissions (see Note 5) and $11.1 million was the excess of fair value over price paid for Founder Shares sold to certain qualified institutional buyers or institutional accredited investors (the “Anchor Investors”). On July 23, 2021, the underwriters exercised their over-allotment option in full and on July 27, 2021, they purchased 4,500,000 additional Units, generating gross proceeds of $45.0 million (the “Over-Allotment”), and incurring offering costs of approximately $2.5 million, of which approximately $1.6 million was for deferred underwriting commissions. Approximately $1.3 million of the offering costs were allocated to derivative warrant liabilities. The Anchor Investors purchased 32,400,000 Units in the Initial Public Offering and the Over-Allotment. None of the Anchor Investors are affiliated with any member of the Company’s management.
Simultaneously with the closing of the Initial Public Offering, the Company completed the sale of 6,333,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) in a private placement (the “Private Placement”), at a price of $1.50 per Private Placement Warrant, to TortoiseEcofin Borrower LLC, a Delaware limited liability company (“TortoiseEcofin Borrower”), generating proceeds of $9.5 million (see Note 4). Concurrently with the consummation of the Over-Allotment on July 27, 2021, TortoiseEcofin Borrower purchased 600,000 additional Private Placement Warrants, generating proceeds of $900,000 (the “Second Private Placement”). Pursuant to that certain securities purchase agreement, dated as of July 19, 2023, HCGP acquired from TortoiseEcofin Borrower all of its limited liability company interests in the Sponsor, as well as 5,893,333 Private Placement Warrants of the Company held by TortoiseEcofin Borrower.
Upon the closing of the Initial Public Offering and the Private Placement on July 22, 2021, and the Over-Allotment and the Second Private Placement on July 27, 2021, the net proceeds thereof consisting of $345.0 million ($10.00 per Unit) were placed in a trust account (the “Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and may be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule
2a-7
of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
 
The Company’s management (“management”) has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, the Over-Allotment and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination, and a majority of the independent directors must approve such initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide the holders (the “Public Shareholders”) of Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes). The
per-share
amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares are classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which the Company adopted in connection with the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) and HCGP agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering, and the Anchor Investors agreed to vote any Founder Shares held by them, in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company adopted an insider trading policy which requires insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material
non-public
information and (ii) clear all trades with the Company’s legal counsel prior to execution. In addition, HCGP and the initial shareholders agreed that they will not be entitled to redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
Notwithstanding the foregoing, if the Company seeks shareholder approval of its Business Combination and does not conduct redemptions in connection with its Business Combination pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.
At the time of the Initial Public Offering, the Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association that would modify the substance or timing of the Company’s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with a Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete its Business Combination within 24 months from the closing of the Initial Public Offering, or July 22, 2023, or 27 months from the closing of the Initial Public Offering, or October 22, 2023, if the Company executed a letter of intent, agreement in principle or definitive agreement for an initial Business Combination within 24 months from the closing of the Initial Public Offering but has not completed the initial Business Combination within such
24-month
period or with respect to any other provision relating to the rights of Public Shareholders, unless the Company will provide the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. On July 20, 2023, the Company issued a press release announcing that it had executed a new
non-binding
letter of intent for a proposed business combination with an industrial renewable power solutions company (the “Letter of Intent”). As a result of the signed Letter of Intent, pursuant to the provisions of the Company’s Amended and Restated Memorandum and Articles of Association, the date by which the Company must consummate its Business Combination was automatically extended from July 22, 2023 to October 22, 2023.
On October 19, 2023, the Company held an extraordinary general meeting in lieu of an annual general meeting of shareholders (the “Extension Meeting”) and filed an amendment to the Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate an initial Business Combination from October 22, 2023 on a monthly basis up to six times until April 22, 2024 (or such earlier date as determined by the board of directors of the Company (the “Board”)). The Company will deposit $258,970.53 per month into the Trust Account, for each calendar month (commencing on October 23, 2023 and on the 23
rd
day of each subsequent month) until April 22, 2024, or portion thereof, that is needed to complete an initial Business Combination. As a result, the date by which the Company must consummate its Business Combination was extended from October 22, 2023 to November 22, 2023 (the “Combination Period”).
 
The Anchor Investors are not entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of a Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a shareholder vote to amend the Amended and Restated Memorandum and Articles of Association in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated a Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete a Business Combination within the Combination Period).
If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses and net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish the Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Board, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
HCGP and the initial shareholders agreed to waive their liquidation rights with respect to the Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. Three of the four underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account with respect to the Company’s Letter of Intent for a proposed business combination with an industrial renewable power solutions company, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
On July 16, 2023, each of Juan J. Daboub, Mary Beth Mandanas and Greg A. Walker resigned from the Board and all committees thereof. None of Mr. Daboub’s, Ms. Mandanas’ or Mr. Walker’s resignation was a result of any disagreement with the Company or the Board on any matters related to the Company’s operation, policies or practices.
In connection with each of Mr. Daboub’s, Ms. Mandanas’ and Mr. Walker’s resignation and in accordance with the terms of the arrangement to which each of them agreed at the time of their respective appointment to the Board, each of Mr. Daboub, Ms. Mandanas and Mr. Walker forfeited to the Company all of the Class B ordinary shares, par value $0.0001 per share, which were previously issued to them in connection with their appointment to the Board.
On July 19, 2023, the Board appointed Thomas D. Hennessy as a director of the Company, effective immediately. Mr. Hennessy replaced Stephen Pang, who resigned as a director of the Company on the same day. Mr. Pang’s resignation was not the result of any disagreement with the Company or the Board. Mr. Pang continues in his positions as President and Chief Financial Officer of the Company.
In addition, Steven Schnitzer resigned as the Vice President, General Counsel and Secretary of the Company on the same day. Mr. Schnitzer’s resignation was not the result of any disagreement with the Company or the Board.
On July 17, 2023, three of the four underwriters for the Company’s Initial Public Offering, consisting of Barclays Capital Inc., Goldman Sachs & Co. LLC and Academy Securities, Inc., agreed to waive all rights to their respective portion of the underwriting commissions (or approximately $9.96 million of the total $12.075 million of the underwriting commissions) with respect to the Company’s proposed Business Combination. As of September 30, 2023, one of the underwriters had further agreed to waive all rights to their respective portion of the underwriting commissions (approximately $4.83 million) with respect to the Company’s proposed Business Combination or to any future Business Combination.
Pursuant to that certain securities purchase agreement, dated as of July 19, 2023, HCGP acquired from TortoiseEcofin Borrower all of its limited liability company interests in the Sponsor, as well as 5,893,333 Private Placement Warrants of the Company held by TortoiseEcofin Borrower. In connection with the transaction, HCGP assumed Tortoise Capital Advisors, L.L.C.’s (“Tortoise Capital Advisors”) rights and obligations under the Administrative Support Agreement (see Note 4).
On July 31, 2023, the Board appointed Jack Leeney, Andrew Lipsher and Matthew Schindel as directors of the Company, effective immediately. Each of the directors serve on the audit, compensation and nominating and corporate governance committees of the Board with Mr. Leeney serving as chair of the compensation committee, Mr. Lipsher serving as chair of the nominating and corporate governance committee, and Mr. Schindel serving as chair of the audit committee. As compensation for their services, the directors will each receive 20,000 Class B ordinary shares of the Company and will also be entitled to cash compensation of $25,000 per quarter.
On September 27, 2023, Darrell Brock, Jr. submitted his resignation as Vice President, Business Development, of the Company, effective immediately. There were no disagreements between the Company and Mr. Brock on any matter related to the Company’s operations, policies, or practices.
 
Liquidity, Capital Resources and Going Concern
As of September 30, 2023, the Company had approximately $13,000 in operating cash and a working capital deficit of approximately $1,192,000.
The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in consideration of Founder Shares, and a loan from the Sponsor of approximately $195,000, under the Note (as defined in Note 4). The Company repaid the Note in full on July 22, 2021 and borrowings under the Note are no longer available.
Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds of $3.5 million from the consummation of the Initial Public Offering, the Over-Allotment, the Private Placement and the Second Private Placement held outside of the Trust Account. In addition, in order to finance general working capital needs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On February 1, 2023, the Company issued a nonconvertible, unsecured promissory note (the “2023 Note”) in the principal amount of $500,000 to TortoiseEcofin Borrower. The 2023 Note does not bear interest and is repayable in full upon consummation of a Business Combination. If the Company does not complete a Business Combination, the 2023 Note will not be repaid and all amounts owed under it will be forgiven. On July 19, 2023, The Company issued a promissory note (the “HCGP Note”) in the principal amount of up to $1,000,000 to HCGP. The HCGP Note was issued in connection with advances HCGP may make in the future to the Company for working capital expenses. The HCGP Note bears no interest and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the election of HCGP, all or a portion of the unpaid principal amount of the HCGP Note may be converted into warrants of the Company at a price of $1.50 per warrant (the “Conversion Warrants”). The Conversion Warrants and their underlying securities are entitled to the registration rights set forth in the HCGP Note. On August 7, 2023 and August 18, 2023, the Company borrowed $100,000 and $280,000, respectively, under the HCGP Note. See Note 4. As of September 30, 2023 and December 31, 2022, there were $335,000 and $0, respectively, outstanding under Working Capital Loans.
In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC
Topic 205-40,
“Presentation of Financial Statements-Going Concern,” management has determined that the liquidity condition and mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. The Company intends to complete a Business Combination before the mandatory liquidation date of November 22, 2023; however, there can be no assurance that the Company will be able to consummate a Business Combination by the Combination Period. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the Combination Period. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.
v3.23.3
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 or any future period.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form
10-K
filed by the Company with the SEC on March 22, 2023.
 
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Merger Sub. There has been no intercompany activity since inception.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of September 30, 2023 and December 31, 2022.
Investments and Cash Held in Trust Account
On June 14, 2023, the Company liquidated the U.S. government treasury obligations or money market funds held in the Trust Account. The funds in the Trust Account are currently maintained in cash in an interest-bearing demand deposit account at a bank until the earlier of consummation of the Company’s initial Business Combination and liquidation. Prior to June 14, 2023, the Company’s portfolio of investments was comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the unaudited condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of September 30, 2023 and December 31, 2022, the Company had approximately $361.3 million and $350.0 million in cash held in the Trust Account, respectively.
 
Fair Value of Financial Instruments
The carrying value of the Company’s assets and liabilities recognized in the condensed consolidated balance sheets, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the fair values for such assets and liabilities either because of the short-term nature of the instruments or because the instrument is recognized at fair value.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued warrants to purchase shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The warrants issued in connection with the Initial Public Offering and the Over-Allotment (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value will be recognized in the Company’s statement of operations. The fair value of the Public Warrants and the Private Placement Warrants were initially measured at fair value using a Black-Scholes Option Pricing Method and Monte Carlo simulation, respectively. Subsequent to the Public Warrants being separately listed and traded from the Units, the fair value of the Public Warrants was measured based on their listed market price, and the fair value of the Private Placement Warrants was estimated by reference to the listed market price of the Public Warrants. The determination of the fair value of the warrant liabilities may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as
non-current
liabilities as their liquidation will not be reasonably expected to require the use of current assets or require the creation of current liabilities.
 
Offering Costs Associated with Initial Public Offering
Offering costs consists of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to the total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as
non-operating
other income in the unaudited condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares issued were charged against their carrying value upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption
As discussed in Note 1, all of the 34,500,000 Class A ordinary shares sold as part of the Units in the Initial Public Offering and the Over-Allotment contain a redemption feature which allows for the redemption of the Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Amended and Restated Memorandum and Articles of Association. In accordance with ASC 480, conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, as of September 30, 2023 and December 31, 2022, all 34,500,000 Class A ordinary shares subject to possible redemption at the redemption amount are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
Under ASC
480-10-S99,
the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the Initial Public Offering and the Over-Allotment, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit. Subsequently, the Company recognized changes in the redemption value as an increase in the redemption value of the Class A ordinary share subject to possible redemption as reflected on the accompanying unaudited condensed consolidated statements of changes in shareholders’ deficit.
Income Taxes
FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman Islands’ federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average of ordinary shares outstanding for the respective period.
 
The calculation of diluted net income does not consider the effect of the Public Warrants and the Private Placement Warrants to purchase an aggregate of 15,558,333 Class A ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares:
 
    
For the Three Months Ended September 30,
     
For the Nine Months Ended September 30,
  
    
2023
     
2022
     
2023
     
2022
  
                                                         
    
Class A
     
Class B
     
Class A
     
Class B
     
Class A
     
Class B
     
Class A
     
Class B
  
                                                         
Basic and diluted net income per ordinary share:
                        
Numerator:
                        
Allocation of net income - basic and diluted
    $ 666,662      $ 166,666      $ 2,409,872      $ 602,468      $ 7,775,670      $ 1,943,918      $ 9,373,599      $ 2,343,400  
Denominator:
                        
Basic and diluted weighted average ordinary shares outstanding
      34,500,000        8,625,000        34,500,000        8,625,000        34,500,000        8,625,000        34,500,000        8,625,000  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income per ordinary share
    $ 0.02      $ 0.02      $ 0.07      $ 0.07      $ 0.23      $ 0.23      $ 0.27      $ 0.27  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.
v3.23.3
Initial Public Offering
 9 Months Ended
Sep. 30, 2023
Initial Public Offering [Abstract]  
INITIAL PUBLIC OFFERING
NOTE 3. INITIAL PUBLIC OFFERING
On July 22, 2021, the Company consummated its Initial Public Offering of 30,000,000 Units, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $28.3 million, of which $10.5 million was for deferred underwriting commissions and $11.1 million was the excess of fair value over price paid of Founder Shares sold to the Anchor Investors. On July 23, 2021, the underwriters exercised their over-allotment option in full and on July 27, 2021, they purchased 4,500,000 additional Units, generating gross proceeds of $45.0 million, and incurring offering costs of approximately $2.5 million, of which approximately $1.6 million was for deferred underwriting commissions. Approximately $1.3 million of the offering costs were allocated to derivative warrant liabilities. The Anchor Investors purchased 32,400,000 Units in the Initial Public Offering and the Over-Allotment. None of the Anchor Investors is affiliated with any member of the Company’s management.
Each Unit consists of one Class A ordinary share and
one-fourth
of one Public Warrant. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 8).
v3.23.3
Related Party Transactions
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
NOTE 4. RELATED PARTY TRANSACTIONS
Founder Shares
On February 9, 2021, the Sponsor paid $
25,000
, or approximately $
0.003
per share, to cover certain expenses on behalf of the Company in consideration of 7,187,500 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”). On February 18, 2021, the Company issued 1,437,500 Class B ordinary shares in connection with a share capitalization, resulting in an aggregate of 8,625,000 Founder Shares outstanding. The Sponsor agreed to forfeit up to 1,125,000 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On July 27, 2021, the underwriters purchased the Units subject to the over-allotment option in full, and as a result, 1,125,000 Founder Shares were no longer subject to possible forfeiture.
In exchange for the Anchor Investors’ participation in the Initial Public Offering as described in Note 3, the Sponsor sold a total of 1,650,000 Founder Shares to the Anchor Investors. The Company determined that the fair value of these Founder Shares was approximately $11.1 million (or $6.73 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these Founder Shares, over the price paid by the Anchor Investors, as a cost of the Initial Public Offering.
 
The holders of the Founder Shares agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until one year after the completion of a Business Combination or earlier if, subsequent to the Business Combination, (x) the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 120 days after the Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property.
Private Placement Warrants
Simultaneously with the closing of the Initial Public Offering, the Company completed the sale of 6,333,333 Private Placement Warrants in a Private Placement, at a price of $1.50 per Private Placement Warrant, to TortoiseEcofin Borrower, generating proceeds of $9.5 million. Concurrently with the consummation of the Over-Allotment on July 27, 2021, TortoiseEcofin Borrower purchased 600,000 additional Private Placement Warrants, generating proceeds of $900,000. Pursuant to that certain securities purchase agreement, dated as of July 19, 2023, HCGP acquired from TortoiseEcofin Borrower all of its limited liability company interests in the Sponsor, as well as 5,893,333 Private Placement Warrants of the Company held by TortoiseEcofin Borrower.
Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants will be
non-redeemable
for cash and exercisable on a cashless basis so long as they are held by TortoiseEcofin Borrower or its permitted transferees.
HCGP, TortoiseEcofin Borrower, the Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of a Business Combination (see Note 8).
Related Party Loans
On February 3, 2021, the Sponsor agreed to loan the Company an aggregate of up to $600,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was
non-interest
bearing and payable upon the consummation of the Initial Public Offering. The Company borrowed approximately $195,000 under the Note and repaid the Note in full on July 22, 2021 and borrowings thereunder are no longer available.
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination is not completed within the Combination Period, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants.
On February 1, 2023, the Company issued a nonconvertible unsecured promissory note (the “2023 Note”) in the principal amount of $500,000 to TortoiseEcofin Borrower. The 2023 Note is not convertible into equity securities, does not bear interest and is repayable in full upon consummation of a Business Combination. If the Company does not complete a Business Combination, the 2023 Note will not be repaid and all amounts owed under it will be forgiven.
On February 1, 2023, March 9, 2023 and May 9, 2023, the Company borrowed $100,000, $50,000 and $185,000, respectively, under the 2023 Note. As of September 30, 2023 and December 31, 2022, the Company had $335,000 and $0, respectively, outstanding under Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans have not been determined and no written agreements exist with respect to such loans.
On July 19, 2023, The Company issued the HCGP Note in the principal amount of up to $1,000,000 to HCGP. The HCGP Note was issued in connection with advances HCGP may make in the future to the Company for working capital expenses. The HCGP Note bears no interest and is repayable in full upon the earlier of (i) the date on which the Company consummates its initial Business Combination and (ii) the date that the winding up of the Company is effective. At the election of HCGP, all or a portion of the unpaid principal amount of the HCGP Note may be converted into warrants that are identical to the Private Placement Warrants (the “Conversion Warrants”) at a price of $1.50 per warrant. The Conversion Warrants and their underlying securities are entitled to the registration rights set forth in the HCGP Note. On August 7, 2023 and August 18, 2023, the Company borrowed $100,000 and $280,000, respectively, under the HCGP Note. As of September 30, 2023, the Company had $380,000 outstanding under the HCGP Note which is recorded as convertible note – related party on the condensed consolidated balance sheets.
 
Due to Related Party
On July 31, 2023, the Board agreed to pay a quarterly salary of $25,000 to each independent director, and an additional $5,000 to the chair of the audit committee, for services rendered prior to or in connection with the completion of the Business Combination. For the three and nine months ended September 30, 2023, the Company expensed $53,333 for services rendered by the independent directors. At September 30, 2023 and December 31, 2022, the Company had accrued approximately $53,333 and $0, respectively, in compensation expense to the independent directors which are included in due to related party on the condensed consolidated balance sheets.
Administrative Support Agreement
On July 19, 2021, the Company entered into an administrative support agreement (the “Administrative Support Agreement”) with Tortoise Capital Advisors, pursuant to which, commencing on the date that the Company’s securities were first listed on the New York Stock Exchange through the earlier of consummation of a Business Combination and the date of the Company’s liquidation, the Company agreed to pay Tortoise Capital Advisors $10,000 per month for office space, utilities and secretarial and administrative support made available to the Company. As of September 30, 2023 and December 31, 2022, the Company had $50,000 and $0 amounts payable for such services, respectively. On July 19, 2023, HCGP assumed Tortoise Capital Advisors’ rights and obligations under the Administrative Support Agreement. For the three and nine months ended September 30, 2023, the Company incurred $30,000 and $90,000, respectively, for such expenses, included as general and administrative expenses—related party on the accompanying unaudited condensed consolidated financial statements of operations. For the three and nine months ended September 30, 2022, the Company incurred $30,000 and $90,000, respectively, for such expenses, included as general and administrative expenses—related party on the accompanying unaudited condensed consolidated financial statements of operations.
In addition, the Sponsor, the Company’s executive officers and directors, or any of their respective affiliates will be reimbursed for any
out-of-pocket
expenses incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, the Company’s executive officers or directors, or the Company’s or their affiliates. Any such payments prior to a Business Combination will be made using funds held outside the Trust Account. During the three and nine months ended September 30, 2023, the Company incurred approximately $354 and $21,000, respectively, of such expenses. During the three and nine months ended September 30, 2022, the Company incurred approximately $16,000 and $66,000, respectively, of such expenses. Approximately $0 and $1,000 was payable and recorded as accounts payable in the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022, respectively.
v3.23.3
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 5. COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares), and any Class A ordinary shares held by the Company’s initial shareholders and HCGP at the completion of the Initial Public Offering or acquired prior to or in connection with a Business Combination, are entitled to registration rights pursuant to a registration rights agreement entered into on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable
lock-up
period, which occurs (i) in the case of the Founder Shares held by the initial shareholders, in accordance with the letter agreement the Company’s initial shareholders entered into, (ii) in the case of the Founder Shares held by the Anchor Investors, in accordance with the investment agreements entered into by and among the Company, the Sponsor and the Anchor Investors and (iii) in the case of the Private Placement Warrants, 30 days after the completion of the Company’s Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
 
Underwriting Agreement
The Company granted the underwriters a
45-day
option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters purchased the Units subject to the over-allotment option in full on July 27, 2021.
The underwriters were entitled to underwriting commissions of $0.20 per Unit, or $6.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per Unit, or $10.5 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
In connection with the consummation of the Over-Allotment on July 27, 2021, the underwriters were paid an additional fee of $900,000, and approximately $1.6 million in additional deferred underwriting commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
On July 17, 2023, three of the four underwriters for the Company’s Initial Public Offering, consisting of Barclays Capital Inc., Goldman Sachs & Co. LLC and Academy Securities, Inc., agreed to waive all rights to their respective portion of the underwriting commissions (or approximately $9.96 million of the total $12.075 million of the underwriting commissions) with respect to the Company’s proposed Business Combination. As of September 30, 2023, one of the underwriters had further agreed to waive all rights to their respective portion of the underwriting commissions (approximately $4.83 million) with respect to the Company’s proposed Business Combination or to any future Business Combination.
Deferred Legal Fees Associated with the Initial Public Offering and Certain Other Matters
The Company entered into an engagement letter to obtain legal advisory services, pursuant to which the Company’s legal counsel agreed to defer half of their fees associated with the Initial Public Offering until the closing of a Business Combination and has arranged the deferral of certain other legal expenses in connection with the Business Combination. As of September 30, 2023 and December 31, 2022, the Company recorded an aggregate of approximately $518,000 for such deferred legal fees in the accompanying condensed consolidated balance sheets.
Risks and Uncertainties
Various social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide. Specifically, the military conflicts in Ukraine the Middle East, and resulting market volatility could adversely affect the Company’s ability to complete a Business Combination. In response to the conflicts between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a Business Combination and the value of the Company’s securities.
Business Combination with One Energy
Business Combination Agreement
On August 14, 2023, the Company entered into a Business Combination Agreement (the “Business Combination Agreement”) with Merger Sub and One Energy.
Pursuant to the Business Combination Agreement, subject to the terms and conditions set forth therein, (i) the Company will transfer by way of continuation from the Cayman Islands to Delaware and domesticate as a Delaware corporation, (ii) Merger Sub will merge with and into One Energy (the “Merger”), with One Energy as the surviving company in the Merger and, as a result of the Merger, One Energy will become a wholly-owned subsidiary of the Company, and (iii) the Company will be renamed “One Power Company”.
Earn Out Consideration
In addition to the base consideration paid at the closing of the Transactions (the “Closing”), for the period of time from 90 days after the Closing and ending on
the 5-year anniversary
of the Closing (“One Energy Earnout Period”), stockholders of One Energy will have the right to earn additional ordinary shares of the Company upon the following terms:
 
  •  
On the date on which the daily volume-weighted average share price of ordinary shares of the Company (“TRTL VWAP”) is greater than $12.50 for any twenty trading days out of thirty consecutive trading days, a
one-time
issuance of 2,500,000 ordinary shares of the Company; and
 
  •  
On the date on which the TRTL VWAP is greater than $15.00 for any twenty trading days out of thirty consecutive trading days, a
one-time
issuance of 2,500,000 ordinary shares of the Company.
 
If, during the One Energy Earnout Period there is a change of control transaction in which the Company or its shareholders have the right to receive consideration implying a value per share (as agreed in good faith by the Board) that is greater than or equal to the applicable TRTL VWAP prices specified above, any applicable earnout shares that have not previously been issued will be issued to the One Energy stockholders.
Sponsor Support Agreement
In connection with the execution of the Business Combination Agreement, the Sponsor entered into a sponsor support agreement (the “Sponsor Support Agreement”) with the Company and One Energy, pursuant to which the Sponsor and each of the Company shareholders party thereto agreed to (a) vote in favor of the Business Combination Agreement and the Transactions, (b) not transfer their shares of the Company during the period between the signing of the Business Combination Agreement and the Closing, (c) waive any adjustment to the conversion ratio set forth in the governing documents of the Company or any other anti-dilution or similar protection with respect to their shares of the Company, and (d) subject 2,250,000 of their shares of the Company to potential vesting and forfeiture based on a stock price based earnout over a
two-year
period, with an early release if the TRTL VWAP exceeds $12.00 per share over 20 out of any 30 consecutive trading days, during such
two-year
period after Closing.
Transaction Support Agreement
In connection with the execution of the Business Combination Agreement, Jereme Kent, CAS Ohio LLC and RES Ohio LLC (collectively, the “Supporting Company Stockholders”) entered into a transaction support agreement (the “Transaction Support Agreement”), pursuant to which, among other things, each such Supporting Company Stockholder agreed to, (a) support and vote in favor of the Business Combination Agreement and the ancillary documents to which One Energy is or will be a party and the Transactions, (b) not transfer their One Energy shares during the interim period prior to the Closing, and (c) take, or cause to be taken, any actions necessary or advisable to cause certain agreements to be terminated effective as of the Closing.
Registration Rights Agreement
Prior to the Closing, the Sponsor and certain One Energy stockholders will enter into an amended and restated registration rights agreement (the “Registration Rights Agreement”). Under the Registration Rights Agreement, the Sponsor and certain other shareholders of the Company and certain One Energy stockholders shall have registration rights that will obligate the Company to register for resale under the Securities Act all or any portion of the (i) ordinary shares of the Company issued to the One Energy stockholders as Transaction Consideration Shares, (ii) the ordinary shares of the Company held by the Sponsor and other legacy shareholders of the Company, (iii) the ordinary shares of the Company issued upon conversion of the ordinary shares of the Company in connection with the Merger, and (iv) the ordinary shares of the Company issuable upon exercise of all warrants held by the Company shareholders (together with any capital shares or other securities issued as a dividend or distribution with respect thereto or in exchange therefor, the “Registrable Securities”). Pursuant to the Registration Rights Agreement, among other things, the Company shall prepare and file a shelf resale registration statement with respect to the registrable securities under the Registration Rights Agreement no later than 60 calendar days prior to the expiration of the applicable post-Closing
lock-up
period. The Company shareholders who hold a majority in interest of the Registrable Securities held by the legacy shareholders of the Company or One Energy stockholders who hold a majority in interest of the Registrable securities held by the legacy One Energy stockholders, will be entitled under the Registration Rights Agreement to make a written demand for registration under the Securities Act of all or part of their Registrable Securities. Subject to certain exceptions, if any time after the Closing, the Company proposes to file a registration statement under the Securities Act with respect to its securities, under the Registration Rights Agreement, the Company shall give notice to the Company shareholders holding Registrable Securities and the One Energy stockholders holding Registrable Securities, as to the proposed filing and offer them an opportunity to register the sale of such number of Registrable Securities as requested by them in writing, subject to customary
cut-backs.
In addition, subject to certain exceptions, the Company shareholders and the One Energy stockholders holding Registrable Securities will be entitled under the Registration Rights Agreement to request in writing that the Company register the resale of any or all of such Registrable Securities on Form
S-3
or
F-3
and any similar short-form registration that may be available at such time. Under the Registration Rights Agreement, the Company will indemnify the holders of Registrable Securities and certain persons or entities related to them, such as their officers, directors, employees, agents and representatives, against any losses or damages resulting from any untrue statement or omission of a material fact in any registration statement or prospectus pursuant to which they sell Registrable Securities, unless such liability arose from their misstatement or omission, and the holders of Registrable Securities, including Registrable Securities in any registration statement or prospectus, will agree to indemnify the Company and certain persons or entities related to the Company, such as its officers and directors and underwriters, against all losses caused by their misstatements or omissions in those documents.
Contingent Stock Rights Agreement
Prior to or in connection with the Closing, the Company, the Sponsor, Jereme Kent and Continental Stock Transfer & Trust Company will enter into a contingent stock rights agreement, pursuant to which Jereme Kent will deposit 5.5 million of the shares of the Company he will receive as consideration in the Transactions into an escrow account to provide certain contingent stock rights to PIPE investors and/or to public shareholders of the Company who do not redeem their shares of the Company in connection with the Transactions, in the event that the post-closing trading price of the combined public company does not equal or exceed a daily VWAP of $12.00 per share over 20 out of any 30 consecutive trading days, during the
two-year
period after Closing.
v3.23.3
Class A Ordinary Shares Subject to Possible Redemption
 9 Months Ended
Sep. 30, 2023
Class A Ordinary Shares Subject to Possible Redemption [Abstract]  
CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION
NOTE 6. CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION
The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 220,000,000 ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of September 30, 2023 and December 31, 2022, there were 34,500,000 Class A ordinary shares outstanding, all of which were subject to possible redemption.
Class A ordinary shares subject to possible redemption reflected on the condensed consolidated balance sheets is reconciled on the following table:
 
Gross proceeds
    $ 345,000,000  
Less:
   
Proceeds allocated to public warrants
      (14,662,500 ) 
Class A ordinary share issuance costs
      (29,430,786 ) 
Plus:
   
Increase in redemption value of Class A ordinary shares subject to possible redemption
      48,984,439  
  
 
 
  
Class A ordinary share subject to possible redemption, December 31, 2022
   
 
349,891,153
 
Plus:
   
Gain on waiver of deferred underwriting fees
      4,624,725  
Increase in redemption value of Class A ordinary shares subject to possible redemption
      6,733,317  
  
 
 
  
Class A ordinary share subject to possible redemption, September 30, 2023
   
$
361,249,195
 
  
 
 
  
v3.23.3
Shareholders' Deficit
 9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
SHAREHOLDERS' DEFICIT
NOTE 7. SHAREHOLDERS’ DEFICIT
Preference Shares
- The Company is authorized to issue 1,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Board. As of September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares
- The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were 34,500,000 Class A ordinary shares issued and outstanding, all subject to possible redemption and therefore classified as temporary equity (see Note 6). In connection with the Extension Meeting, shareholders holding 17,235,298 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account.
Class
 B Ordinary Shares
- The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. In February 2021, the Company issued 7,187,500 Class B ordinary shares to the Sponsor in exchange for the payment of $25,000, or approximately $0.003 per share. On February 18, 2021, the Company issued 1,437,500 Class B ordinary shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Founder Shares. All shares and associated amounts have been retroactively adjusted to reflect the share capitalization. Of the 8,625,000 Class B ordinary shares, an aggregate of up to 1,125,000 shares were subject to forfeiture to the Company by the Sponsor for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that holders of the Founder Shares would collectively own 20% of the Company’s issued and outstanding ordinary shares. The underwriters purchased the units subject to the over-allotment option in full on July 27, 2021; therefore, these 1,125,000 Class B ordinary shares were no longer subject to possible forfeiture. As a result, as of September 30, 2023 and December 31, 2022, there were 8,625,000 Class B ordinary shares outstanding and none subject to forfeiture.
Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders, except that in respect of any vote or votes to continue the Company in a jurisdiction outside the Cayman Islands (including, but not limited to, the approval of the organizational documents of the Company in such other jurisdiction), holders of Class B ordinary shares will have ten votes per share and holders of Class A ordinary shares will have one vote per share, and except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the election of the Company’s directors (and may also remove a member of the Board for any reason) prior to a Business Combination.
The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a
one-for-one
basis, subject to adjustment for share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of the total number of all ordinary shares outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination). In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than
one-to-one.
v3.23.3
Derivative Warrant Liabilities
 9 Months Ended
Sep. 30, 2023
Derivative Warrant Liabilities [Abstract]  
DERIVATIVE WARRANT LIABILITIES
NOTE 8. DERIVATIVE WARRANT LIABILITIES
As of September 30, 2023 and December 31, 2022, 8,625,000 Public Warrants and 6,933,333 Private Placement Warrants were outstanding.
The Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination; provided that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company registered the Class A ordinary shares issuable upon exercise of the warrants and agreed to use commercially reasonable efforts to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the board and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Newly Issued Price.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be
non-redeemable
so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the initial shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash (except as described herein with respect to the Private Placement Warrants):
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption; and
 
  •  
if, and only if, the last sale price of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
 
The Company will not redeem the warrants for cash unless a registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the
30-day
redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act.
Commencing 90 days after the warrants become exercisable, the Company may redeem the outstanding warrants for Class A ordinary shares:
 
  •  
in whole and not in part;
 
  •  
at a price equal to a number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption; and
 
  •  
if, and only if, the last sale price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted per share
sub-divisions,
share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
The “fair market value” of Class A ordinary shares shall mean the average reported last sale price of Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.
In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
v3.23.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2023
Fair Value Measurements [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 9. FAIR VALUE MEASUREMENTS
The following tables presents information about the Company’s assets and liabilities as of September 30, 2023 and December 31, 2022, that are measured at fair value on a recurring basis, by level within the fair value hierarchy:
September 30, 2023
 
Description
   
Quoted
Prices in
Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Liabilities:
         
Derivative warrant liabilities - Public Warrants
    $  1,466,250      $ —        $ —    
Derivative warrant liabilities - Private Placement Warrants
    $ —        $ 1,178,667      $ —    
December 31, 2022
 
Description
   
Quoted
Prices in
Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Assets:
         
Investments and cash held in Trust Account
    $ 349,991,153      $ —        $ —    
Liabilities:
         
Derivative warrant liabilities - Public Warrants
    $ 1,725,000      $ —        $ —    
Derivative warrant liabilities - Private Placement Warrants
    $ —        $ 1,386,667      $ —    
Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of Public Warrants was transferred from a Level 1 measurement to a Level 2 measurement due to lack of trading activity as of September 30, 2023 and 2022. As of September 30, 2023 and 2022, the estimated fair value of the Public Warrants was transferred back to a Level 1 measurement due to adequate trading activity.
 
The Public Warrants issued in connection with the Initial Public Offering and the Over-Allotment, and the Private Placement Warrants sold in the Private Placement and the Second Private Placement were initially measured at fair value using a Black-Scholes option pricing model and a Monte Carlo simulation, respectively. For periods subsequent to the detachment of the Public Warrants from the Units, the fair value of the Public Warrants is based on the observable listed price for such warrants, and the fair value of the warrants issued in the Private Placement and the Second Private Placement was estimated by reference to the listed market price of the Public Warrants.
For the three and nine months ended September 30, 2023, the Company recognized a loss and gain resulting from an increase and decrease in fair value of the derivative warrant liabilities of approximately $1.9 million and $467,000, respectively, presented as change in fair value of derivative warrant liabilities in the accompanying unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2022, the Company recognized a gain resulting from a decrease in the fair value of the derivative warrant liabilities of approximately $1.9 million and $11 million, respectively, presented as change in the fair value of derivative warrant liabilities in the accompanying unaudited condensed consolidated statements of operations.
v3.23.3
Subsequent Events
 9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed consolidated financial statements were issued. Based on this review, besides the below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements, other than as described below.
On October 19, 2023, the Company held the Extension Meeting. At the Extension Meeting, the shareholders of the Company approved, among other things, a proposal to amend by special resolution the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate an initial Business Combination from October 22, 2023 on a monthly basis up to six times until April 22, 2024 (or such earlier date as determined by the Board in its sole discretion). Shareholders holding 17,235,298 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $180.9 million (approximately $10.49 per share) was removed from the Trust Account to pay such holders.
On October 20, 2023, the Company issued a promissory note (the “Extension Note”) in the aggregate principal amount of up to $1,553,823.18 (“Extension Funds”) to the Sponsor, pursuant to which the Extension Funds will be deposited into the Company’s Trust Account for the benefit of each outstanding Public Share that was not redeemed in connection with the Meeting. The Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of the Company’s initial Business Combination, and (b) the date of the liquidation of the Company.
The Company will deposit $258,970.53 per month into the Trust Account, which equates to $0.015 per remaining Public Share, for each calendar month (commencing on October 23, 2023 and on the 23rd day of each subsequent month) until April 22, 2024, or portion thereof, that is needed to complete an initial Business Combination, for up to an aggregate of $1,553,823.18.
v3.23.3
Accounting Policies, by Policy (Policies)
 9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 or any future period.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form
10-K
filed by the Company with the SEC on March 22, 2023.
Principles of Consolidation
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Merger Sub. There has been no intercompany activity since inception.
Emerging Growth Company
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of September 30, 2023 and December 31, 2022.
Investments and Cash Held in Trust Account
Investments and Cash Held in Trust Account
On June 14, 2023, the Company liquidated the U.S. government treasury obligations or money market funds held in the Trust Account. The funds in the Trust Account are currently maintained in cash in an interest-bearing demand deposit account at a bank until the earlier of consummation of the Company’s initial Business Combination and liquidation. Prior to June 14, 2023, the Company’s portfolio of investments was comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the unaudited condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of September 30, 2023 and December 31, 2022, the Company had approximately $361.3 million and $350.0 million in cash held in the Trust Account, respectively.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The carrying value of the Company’s assets and liabilities recognized in the condensed consolidated balance sheets, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the fair values for such assets and liabilities either because of the short-term nature of the instruments or because the instrument is recognized at fair value.
Fair Value Measurements
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued warrants to purchase shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.
The warrants issued in connection with the Initial Public Offering and the Over-Allotment (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value will be recognized in the Company’s statement of operations. The fair value of the Public Warrants and the Private Placement Warrants were initially measured at fair value using a Black-Scholes Option Pricing Method and Monte Carlo simulation, respectively. Subsequent to the Public Warrants being separately listed and traded from the Units, the fair value of the Public Warrants was measured based on their listed market price, and the fair value of the Private Placement Warrants was estimated by reference to the listed market price of the Public Warrants. The determination of the fair value of the warrant liabilities may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as
non-current
liabilities as their liquidation will not be reasonably expected to require the use of current assets or require the creation of current liabilities.
Offering Costs Associated with Initial Public Offering
Offering Costs Associated with Initial Public Offering
Offering costs consists of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to the total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as
non-operating
other income in the unaudited condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares issued were charged against their carrying value upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption
Class A Ordinary Shares Subject to Possible Redemption
As discussed in Note 1, all of the 34,500,000 Class A ordinary shares sold as part of the Units in the Initial Public Offering and the Over-Allotment contain a redemption feature which allows for the redemption of the Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Amended and Restated Memorandum and Articles of Association. In accordance with ASC 480, conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, as of September 30, 2023 and December 31, 2022, all 34,500,000 Class A ordinary shares subject to possible redemption at the redemption amount are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
Under ASC
480-10-S99,
the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the Initial Public Offering and the Over-Allotment, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit. Subsequently, the Company recognized changes in the redemption value as an increase in the redemption value of the Class A ordinary share subject to possible redemption as reflected on the accompanying unaudited condensed consolidated statements of changes in shareholders’ deficit.
Income Taxes
Income Taxes
FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman Islands’ federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed consolidated financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income Per Ordinary Share
Net Income Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average of ordinary shares outstanding for the respective period.
 
The calculation of diluted net income does not consider the effect of the Public Warrants and the Private Placement Warrants to purchase an aggregate of 15,558,333 Class A ordinary shares in the calculation of diluted income per share, because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares:
 
    
For the Three Months Ended September 30,
     
For the Nine Months Ended September 30,
  
    
2023
     
2022
     
2023
     
2022
  
                                                         
    
Class A
     
Class B
     
Class A
     
Class B
     
Class A
     
Class B
     
Class A
     
Class B
  
                                                         
Basic and diluted net income per ordinary share:
                        
Numerator:
                        
Allocation of net income - basic and diluted
    $ 666,662      $ 166,666      $ 2,409,872      $ 602,468      $ 7,775,670      $ 1,943,918      $ 9,373,599      $ 2,343,400  
Denominator:
                        
Basic and diluted weighted average ordinary shares outstanding
      34,500,000        8,625,000        34,500,000        8,625,000        34,500,000        8,625,000        34,500,000        8,625,000  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income per ordinary share
    $ 0.02      $ 0.02      $ 0.07      $ 0.07      $ 0.23      $ 0.23      $ 0.27      $ 0.27  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Recent Accounting Pronouncements
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.
v3.23.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of Basic and Diluted Net Income Per Share
The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares:
 
    
For the Three Months Ended September 30,
     
For the Nine Months Ended September 30,
  
    
2023
     
2022
     
2023
     
2022
  
                                                         
    
Class A
     
Class B
     
Class A
     
Class B
     
Class A
     
Class B
     
Class A
     
Class B
  
                                                         
Basic and diluted net income per ordinary share:
                        
Numerator:
                        
Allocation of net income - basic and diluted
    $ 666,662      $ 166,666      $ 2,409,872      $ 602,468      $ 7,775,670      $ 1,943,918      $ 9,373,599      $ 2,343,400  
Denominator:
                        
Basic and diluted weighted average ordinary shares outstanding
      34,500,000        8,625,000        34,500,000        8,625,000        34,500,000        8,625,000        34,500,000        8,625,000  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net income per ordinary share
    $ 0.02      $ 0.02      $ 0.07      $ 0.07      $ 0.23      $ 0.23      $ 0.27      $ 0.27  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
v3.23.3
Class A Ordinary Shares Subject to Possible Redemption (Tables)
 9 Months Ended
Sep. 30, 2023
Class A Ordinary Shares Subject to Possible Redemption [Abstract]  
Schedule of Ordinary Shares Subject to Possible Redemption
Class A ordinary shares subject to possible redemption reflected on the condensed consolidated balance sheets is reconciled on the following table:
 
Gross proceeds
    $ 345,000,000  
Less:
   
Proceeds allocated to public warrants
      (14,662,500 ) 
Class A ordinary share issuance costs
      (29,430,786 ) 
Plus:
   
Increase in redemption value of Class A ordinary shares subject to possible redemption
      48,984,439  
  
 
 
  
Class A ordinary share subject to possible redemption, December 31, 2022
   
 
349,891,153
 
Plus:
   
Gain on waiver of deferred underwriting fees
      4,624,725  
Increase in redemption value of Class A ordinary shares subject to possible redemption
      6,733,317  
  
 
 
  
Class A ordinary share subject to possible redemption, September 30, 2023
   
$
361,249,195
 
  
 
 
  
v3.23.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Measurements [Abstract]  
Schedule of Assets and Liabilities
The following tables presents information about the Company’s assets and liabilities as of September 30, 2023 and December 31, 2022, that are measured at fair value on a recurring basis, by level within the fair value hierarchy:
September 30, 2023
 
Description
   
Quoted
Prices in
Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Liabilities:
         
Derivative warrant liabilities - Public Warrants
    $  1,466,250      $ —        $ —    
Derivative warrant liabilities - Private Placement Warrants
    $ —        $ 1,178,667      $ —    
December 31, 2022
 
Description
   
Quoted
Prices in
Active
Markets
(Level 1)
     
Significant
Other
Observable
Inputs
(Level 2)
     
Significant
Other
Unobservable
Inputs
(Level 3)
  
Assets:
         
Investments and cash held in Trust Account
    $ 349,991,153      $ —        $ —    
Liabilities:
         
Derivative warrant liabilities - Public Warrants
    $ 1,725,000      $ —        $ —    
Derivative warrant liabilities - Private Placement Warrants
    $ —        $ 1,386,667      $ —    
v3.23.3
Description of Organization, Business Operations and Basis of Presentation (Details) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Oct. 19, 2023
Jul. 19, 2023
Jul. 17, 2023
Jul. 27, 2021
Jul. 22, 2021
Sep. 30, 2023
Dec. 31, 2022
Oct. 20, 2023
Aug. 18, 2023
Aug. 07, 2023
Jul. 31, 2023
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Share price per share (in Dollars per share)       $ 10              
Private placement warrants (in Shares)   5,893,333                  
Net proceeds       $ 345,000,000              
Percentage of fair market value           80.00%          
Public per share (in Dollars per share)           $ 10          
Net tangible assets           $ 5,000,001          
Business combination percentage           100.00%          
Public shares redeem percentage           100.00%          
Interest expenses           $ 100,000          
Operating cash           13,000          
Working capital           1,192,000          
Loan proceeds           195,000          
Principal amount           500,000          
Working capital loans           335,000 $ 0        
Principal amount   $ 1,000,000                  
Price of per warrants (in Dollars per share)   $ 1.5                  
Borrowed amount                 $ 280,000 $ 100,000  
Underwriting commissions waived           4,830,000          
Subsequent Event [Member] | Extraordinary General Meeting Held To Extend The Date By Which Business Combination Shall be Consummated [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Latest date before which business combination shall be consummated Apr. 22, 2024                    
Per month contribution into the trust account $ 258,970.53             $ 258,970.53      
Initial Public Offering [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Shares units (in Shares)         30,000,000            
Share price per share (in Dollars per share)         $ 10            
Gross proceeds         $ 300,000,000            
Offering costs         28,300,000            
Deferred underwriting commission     $ 12,075,000.000   10,500,000            
Excess of fair value over price paid         11,100,000            
Payment to offering cost           25,000          
Net proceeds           3,500,000          
Underwriting commission     $ 9,960,000   $ 11,100,000            
Over-Allotment [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Gross proceeds       45,000,000              
Offering costs       2,500,000              
Deferred underwriting commission       $ 1,600,000              
Purchased additional shares (in Shares)       4,500,000              
Offering costs were allocated to derivative warrant liabilities           $ 1,300,000          
Investors purchased units (in Shares)           32,400,000          
Private Placement Warrant [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Gross proceeds           $ 9,500,000          
Warrant shares (in Shares)   5,893,333                  
Warrant [Member] | Private Placement Warrant [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Sale of warrants units (in Shares)           6,333,333          
Share price per share (in Dollars per share)           $ 1.5          
Borrower purchased share (in Shares)       600,000              
Warrant [Member] | Second Private Placement [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Gross proceeds       $ 900,000              
Class A Ordinary Shares [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Public share percentage           20.00%          
Ordinary shares, par value (in Dollars per share)           $ 0.0001 $ 0.0001        
Class B Ordinary Shares [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Ordinary shares, par value (in Dollars per share)           $ 0.0001 $ 0.0001        
Class B Ordinary Shares [Member] | Jack Leeney [Member] | Audit Committee [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Common stock issuable                     20,000
Compensation per quarter payable                     $ 25,000
Class B Ordinary Shares [Member] | Andrew Lipsher [Member] | Compensation Committee [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Common stock issuable                     20,000
Compensation per quarter payable                     $ 25,000
Class B Ordinary Shares [Member] | Mathew Schindel [Member] | Nomination and Remuneration Committee [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Common stock issuable                     20,000
Compensation per quarter payable                     $ 25,000
Business Combination [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Business combination post transaction own percentage           50.00%          
Series of Individually Immaterial Business Acquisitions [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Share price per share (in Dollars per share)           $ 10          
Trust account price per share (in Dollars per share)           10          
Series of Individually Immaterial Business Acquisitions [Member] | Transaction agreement [Member]                      
Description of Organization, Business Operations and Basis of Presentation (Details) [Line Items]                      
Trust account price per share (in Dollars per share)           $ 10          
v3.23.3
Summary of Significant Accounting Policies (Details) - USD ($)
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies Details Line Items    
Federal deposit insurance (in Dollars) $ 250,000  
Cash held in the trust account (in Dollars) $ 361,300,000 $ 350,000,000
Initial public offering 34,500,000  
Shares subject to possible redemption 34,500,000 34,500,000
Common Class A [Member]    
Summary of Significant Accounting Policies Details Line Items    
Purchase an aggregate of shares 15,558,333  
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income Per Share - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Common Class A [Member]        
Basic and diluted net income per ordinary share:        
Allocation of net income - basic and diluted $ 666,662 $ 2,409,872 $ 7,775,670 $ 9,373,599
Denominator:        
Basic and diluted weighted average ordinary shares outstanding 34,500,000 34,500,000 34,500,000 34,500,000
Basic net income per ordinary share $ 0.02 $ 0.07 $ 0.23 $ 0.27
Common Class B [Member]        
Basic and diluted net income per ordinary share:        
Allocation of net income - basic and diluted $ 166,666 $ 602,468 $ 1,943,918 $ 2,343,400
Denominator:        
Basic and diluted weighted average ordinary shares outstanding 8,625,000 8,625,000 8,625,000 8,625,000
Basic net income per ordinary share $ 0.02 $ 0.07 $ 0.23 $ 0.27
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income Per Share (Parentheticals) - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Common Class A [Member]        
Schedule Of Basic And Diluted Net Income Per Share Line Items        
Weighted average number of ordinary shares - diluted 34,500,000 34,500,000 34,500,000 34,500,000
Diluted net income per ordinary share $ 0.02 $ 0.07 $ 0.23 $ 0.27
Common Class B [Member]        
Schedule Of Basic And Diluted Net Income Per Share Line Items        
Weighted average number of ordinary shares - diluted 8,625,000 8,625,000 8,625,000 8,625,000
Diluted net income per ordinary share $ 0.02 $ 0.07 $ 0.23 $ 0.27
v3.23.3
Initial Public Offering (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 9 Months Ended
Jul. 17, 2023
Jul. 27, 2021
Jul. 22, 2021
Sep. 30, 2023
Initial Public Offering Details Line Items        
Number of shares issued (in Shares)   4,500,000    
Gross proceeds   $ 45,000    
IPO [Member]        
Initial Public Offering Details Line Items        
Number of shares issued (in Shares)     30,000,000  
Share price per share (in Dollars per share)     $ 10  
Gross proceeds     $ 300,000  
Offering costs     28,300  
Deferred underwriting commissions $ 12,075   10,500  
Underwriting commission $ 9,960   $ 11,100  
Over-Allotment Option [Member]        
Initial Public Offering Details Line Items        
Offering costs   2,500    
Deferred underwriting commissions   $ 1,600    
Offering costs allocated to derivate warrant liabilities       $ 1,300
Sale of units (in Shares)       32,400,000
Class A Ordinary Shares [Member]        
Initial Public Offering Details Line Items        
Warrants exercise price per share (in Shares)       11.5
v3.23.3
Related Party Transactions (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 18, 2023
Aug. 07, 2023
Jul. 19, 2023
May 09, 2023
Mar. 09, 2023
Feb. 01, 2023
Dec. 31, 2022
Jul. 19, 2021
Feb. 09, 2021
Feb. 03, 2021
Jul. 27, 2021
Feb. 18, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jul. 31, 2023
Jul. 22, 2021
Related Party Transactions Details Line Items                                      
Founder shares                     $ 1,125,000                
Issued and outstanding ordinary shares percentage                       20.00%              
Sponsor transferred founder shares (in Shares)                             1,650,000        
Purchased additional private placement warrants (in Shares)                     600,000                
Private placement warrant                             $ 5,893,333        
Borrowed amount $ 280,000 $ 100,000                                  
Principal amount           $ 500,000                          
Amount borrowed       $ 185,000 $ 50,000 $ 100,000                          
Outstanding working capital loans             $ 0               335,000        
Notes issued     $ 1,000,000                                
Expenses amount     $ 1.5                   $ 354 $ 16,000 21,000 $ 66,000      
Office rent               $ 10,000                      
General and administrative expenses - related party                         30,000 $ 30,000 90,000 $ 90,000      
Amount payable for service                             50,000   $ 0    
Accounts payable             1,000           0   0   1,000    
Convertible debt non current                       380,000   380,000      
Other liabilities non current                       53,333   53,333      
Audit Committee [Member]                                      
Related Party Transactions Details Line Items                                      
Additional compensation per quarter payable                                   $ 5,000  
Independent Director One [Member]                                      
Related Party Transactions Details Line Items                                      
Compensation per quarter payable                                   25,000  
Independent Director Two [Member]                                      
Related Party Transactions Details Line Items                                      
Compensation per quarter payable                                   25,000  
Independent Director Three [Member]                                      
Related Party Transactions Details Line Items                                      
Compensation per quarter payable                                   $ 25,000  
Independent Director One Two And Three [Member]                                      
Related Party Transactions Details Line Items                                      
Compensation expenses                         53,333   53,333        
Other liabilities non current             $ 0           $ 53,333   $ 53,333   $ 0    
Founder Shares [Member]                                      
Related Party Transactions Details Line Items                                      
Sponsor paid                 $ 25,000                    
Sponsor par value (in Dollars per share)                 $ 0.003                    
Over-Allotment Option [Member]                                      
Related Party Transactions Details Line Items                                      
Issuance of ordinary shares (in Shares)                             4,500,000        
Founder shares                       $ 1,125,000              
Generating proceeds                     $ 900,000                
Private Placement Warrant [Member]                                      
Related Party Transactions Details Line Items                                      
Sale of private placement warrants (in Shares)                             6,333,333        
Warrant price (in Dollars per share)                         $ 1.5   $ 1.5        
Generating proceeds                             $ 9,500,000        
Initial Public Offering [Member]                                      
Related Party Transactions Details Line Items                                      
Cover expenses                   $ 600,000                  
Class B Ordinary Shares [Member]                                      
Related Party Transactions Details Line Items                                      
Issuance of ordinary shares (in Shares)                       1,437,500              
Aggregate of founder shares outstanding (in Shares)                       8,625,000              
Class B Ordinary Shares [Member] | Founder Shares [Member]                                      
Related Party Transactions Details Line Items                                      
Issuance of ordinary shares (in Shares)                 7,187,500                    
Ordinary shares, par value (in Dollars per share)                 $ 0.0001                    
Class A Ordinary Shares [Member]                                      
Related Party Transactions Details Line Items                                      
Ordinary shares equals or exceeds (in Dollars per share)                             $ 12        
Class A Ordinary Shares [Member] | Private Placement Warrant [Member]                                      
Related Party Transactions Details Line Items                                      
Warrant exercisable (in Dollars per share)                             11.5        
Business Combination [Member]                                      
Related Party Transactions Details Line Items                                      
Warrant price (in Dollars per share)                         $ 1.5   $ 1.5        
Working capital loans                             $ 1,500,000        
Related Party Loans [Member]                                      
Related Party Transactions Details Line Items                                      
Borrowed amount                                     $ 195,000
Amount borrowed $ 280,000 $ 100,000                                  
Monte Carlo [Member]                                      
Related Party Transactions Details Line Items                                      
Fair value of founder shares (in Dollars per share)                             $ 11,100,000        
Fair value of founder shares per share (in Dollars per share)                             $ 6.73        
HCGP [Member] | Convertible Debt [Member]                                      
Related Party Transactions Details Line Items                                      
Convertible debt non current                         $ 380,000   $ 380,000        
v3.23.3
Commitments and Contingencies (Details) - USD ($)
 1 Months Ended 9 Months Ended
Aug. 14, 2023
Jul. 17, 2023
Jul. 27, 2021
Jul. 22, 2021
Sep. 30, 2023
Dec. 31, 2022
Commitmentsand Contingencies Details Line Items            
Underwriting commissions waived         $ 4,830,000  
TRTL [Member] | Sponsor Support Agreement [Member]            
Commitmentsand Contingencies Details Line Items            
Volume weighted average share price for earnout payment $ 12          
Number of trading days for calculating the share price 20 days          
Number of consecutive trading days for calculating the share price 30 days          
Period after closing of business combination for calculation of share price         2 years  
TRTL [Member] | Contingent Stock Rights Agreement [Member]            
Commitmentsand Contingencies Details Line Items            
Volume weighted average share price for earnout payment $ 12          
Number of trading days for calculating the share price 20 days          
Number of consecutive trading days for calculating the share price 30 days          
Number of shares agreed to be deposited into the escrow account 5,500,000          
TRTL [Member] | Maximum [Member] | One Energy [Member] | Business Combination Agreement [Member]            
Commitmentsand Contingencies Details Line Items            
Time period within which earnout consideration shall be paid 5 years          
TRTL [Member] | Minimum [Member] | One Energy [Member] | Business Combination Agreement [Member]            
Commitmentsand Contingencies Details Line Items            
Time period within which earnout consideration shall be paid 90 days          
TRTL [Member] | Earnout Condition One [Member] | One Energy [Member] | Business Combination Agreement [Member]            
Commitmentsand Contingencies Details Line Items            
Volume weighted average share price for earnout payment $ 12.5          
Number of trading days for calculating the share price 20 days          
Number of consecutive trading days for calculating the share price 30 days          
Common stock shares issuable 2,500,000          
TRTL [Member] | Earnout Condition Two [Member] | One Energy [Member] | Business Combination Agreement [Member]            
Commitmentsand Contingencies Details Line Items            
Volume weighted average share price for earnout payment $ 15          
Number of trading days for calculating the share price 20 days          
Number of consecutive trading days for calculating the share price 30 days          
Common stock shares issuable 2,500,000          
Over-Allotment Option [Member]            
Commitmentsand Contingencies Details Line Items            
Shares issued additional Units (in Shares)         4,500,000  
Share price per unit (in Dollars per share)         $ 0.35  
Underwriters additional fee     $ 900,000      
Deferred underwriting         $ 10,500,000  
Additional deferred underwriting commissions     1,600,000      
Deferred underwriting commissions     $ 1,600,000      
IPO [Member]            
Commitmentsand Contingencies Details Line Items            
Share price per unit (in Dollars per share)         $ 0.2  
Underwriters additional fee         $ 6,000,000  
Underwriting commissions   $ 9,960,000   $ 11,100,000    
Deferred underwriting commissions   $ 12,075,000.000   $ 10,500,000    
Deferred Legal Fees Associated with The Initial Public Offering [Member]            
Commitmentsand Contingencies Details Line Items            
Aggregate amount         $ 518,000 $ 518,000
v3.23.3
Class A Ordinary Shares Subject to Possible Redemption (Details) - Class A Ordinary Shares [Member] - $ / shares
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Class A Ordinary Shares Subject to Possible Redemption (Details) [Line Items]    
Ordinary shares, shares authorized 220,000,000  
Ordinary shares, par value (in Dollars per share) $ 0.0001  
Common stock voting Holders of the Company’s Class A ordinary shares are entitled to one vote for each share  
Ordinary shares, shares outstanding 34,500,000 34,500,000
v3.23.3
Class A Ordinary Shares Subject to Possible Redemption (Details) - Schedule of Ordinary Shares Subject to Possible Redemption - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Shares Subject To Mandatory Redemption By Settlement Terms Line Items          
Gross proceeds         $ 345,000,000
Less:          
Proceeds allocated to public warrants $ (1,900,000) $ (1,900,000) $ (467,000) $ (11,000,000) $ (14,662,500)
Class A ordinary share issuance costs (in Shares)         (29,430,786)
Plus:          
Gain on waiver of deferred underwriting fees     4,624,725    
Increase in redemption value of Class A ordinary shares subject to possible redemption     6,733,317   $ 48,984,439
Class A ordinary share subject to possible redemption $ 361,249,195   $ 361,249,195   $ 349,891,153
v3.23.3
Shareholders' Deficit (Details) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Jul. 27, 2021
Feb. 18, 2021
Feb. 28, 2021
Sep. 30, 2023
Dec. 31, 2022
Shareholders Deficit Details Line Items          
Preferred stock, shares authorized       1,000,000 1,000,000
Converted basis, percentage       20.00%  
Common Class A [Member]          
Shareholders Deficit Details Line Items          
Ordinary shares, shares authorized       200,000,000 200,000,000
Ordinary shares, par value (in Dollars per share)       $ 0.0001 $ 0.0001
Ordinary shares subject to possible redemption, shares issued       34,500,000 34,500,000
Ordinary shares subject to possible redemption, shares outstanding       34,500,000 34,500,000
Issued and outstanding ordinary shares   20.00%      
Ordinary shares outstanding      
Temporary equity stock shares subject to redemption shares       17,235,298 17,235,298
Common Class B [Member]          
Shareholders Deficit Details Line Items          
Ordinary shares, shares authorized       20,000,000 20,000,000
Ordinary shares, par value (in Dollars per share)       $ 0.0001 $ 0.0001
Ordinary shares issued     7,187,500    
Exchange payment (in Dollars)     $ 25,000    
Per share (in Dollars per share)     $ 0.003    
Share capitalization   1,437,500      
Aggregate of founder shares   8,625,000      
Aggregate of shares   8,625,000      
Aggregate of shares were subject to forfeiture   1,125,000      
No longer subject to possible forfeiture 1,125,000        
Ordinary shares outstanding       8,625,000 8,625,000
v3.23.3
Derivative Warrant Liabilities (Details) - $ / shares
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Derivative Warrant Liabilities Details Line Items    
Warrants expire 5 years  
Effective price per share $ 9.2  
Newly issued price, percentage 115.00%  
Common Class A [Member]    
Derivative Warrant Liabilities Details Line Items    
Minimum Period Of Prior Written Notice Of Redemption Of Warrants 30 days  
Number Of Trading Day For Determining Prior Redemption Notice Period 10 days  
Number Of Days Of Redemption Period 30 days  
From The Completion Of Business Combination [Member]    
Derivative Warrant Liabilities Details Line Items    
Class Of Warrants Or Rights Period After Which The Warrants Are Exercisable 90 days  
Share Price Equal Or Exceeds Ten Rupees Per Dollar [Member] | Common Class A [Member]    
Derivative Warrant Liabilities Details Line Items    
Share Price $ 10  
Public Warrants [Member]    
Derivative Warrant Liabilities Details Line Items    
Warrant outstanding (in Shares) 8,625,000  
Private Placement Warrants [Member]    
Derivative Warrant Liabilities Details Line Items    
Warrant outstanding (in Shares)   6,933,333
Class Of Warrants Or Rights Redemption Price Per Unit $ 0.01  
Notice Period To Be Given Prior To Redemption 30 days  
Period After Initial Business Combination To Allow Transfer Of Shares 30 days  
Private Placement Warrants [Member] | Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member]    
Derivative Warrant Liabilities Details Line Items    
Share Price $ 18  
Number Of Trading Days For Determining The Share Price 20 days  
Number Of Consecutive Trading Days For Determining The Share Price 30 days  
Private Placement [Member]    
Derivative Warrant Liabilities Details Line Items    
Warrants become exercisable, description Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash (except as described herein with respect to the Private Placement Warrants):     •   in whole and not in part;     •   at a price of $0.01 per warrant;     •   upon a minimum of 30 days’ prior written notice of redemption; and     •   if, and only if, the last sale price of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.  
Warrant [Member]    
Derivative Warrant Liabilities Details Line Items    
Exercise price per share $ 11.5  
v3.23.3
Fair Value Measurements (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Fair Value Measurements [Abstract]          
Derivative warrant liabilities $ 1,900,000 $ 1,900,000 $ 467,000 $ 11,000,000 $ 14,662,500
v3.23.3
Fair Value Measurements (Details) - Schedule of Assets and Liabilities - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Assets:    
Investments and cash held in Trust Account $ 361,349,195 $ 349,991,153
Liabilities:    
Derivative warrant liabilities 2,644,917 3,111,667
Quoted Prices in Active Markets (Level 1) [Member]    
Assets:    
Investments and cash held in Trust Account   349,991,153
Quoted Prices in Active Markets (Level 1) [Member] | Public Warrants [Member]    
Liabilities:    
Derivative warrant liabilities 1,466,250 1,725,000
Quoted Prices in Active Markets (Level 1) [Member] | Private Placement Warrants [Member]    
Liabilities:    
Derivative warrant liabilities
Significant Other Observable Inputs (Level 2) [Member]    
Assets:    
Investments and cash held in Trust Account  
Significant Other Observable Inputs (Level 2) [Member] | Public Warrants [Member]    
Liabilities:    
Derivative warrant liabilities
Significant Other Observable Inputs (Level 2) [Member] | Private Placement Warrants [Member]    
Liabilities:    
Derivative warrant liabilities 1,178,667 1,386,667
Significant Other Unobservable Inputs (Level 3) [Member]    
Assets:    
Investments and cash held in Trust Account  
Significant Other Unobservable Inputs (Level 3) [Member] | Public Warrants [Member]    
Liabilities:    
Derivative warrant liabilities
Significant Other Unobservable Inputs (Level 3) [Member] | Private Placement Warrants [Member]    
Liabilities:    
Derivative warrant liabilities
v3.23.3
Subsequent Events (Details) - USD ($)
Oct. 19, 2023
Oct. 20, 2023
Sep. 30, 2023
Subsequent Events Details Line Items      
Debt instrument face value     $ 500,000
Subsequent Event [Member] | Extraordinary General Meeting Held To Extend The Date By Which Business Combination Shall be Consummated [Member]      
Subsequent Events Details Line Items      
Latest date before which business combination shall be consummated Apr. 22, 2024    
Per share amount to be contributed to the trust account   $ 0.015  
Per month contribution into the trust account $ 258,970.53 $ 258,970.53  
Aggregate amount to be contributed to the trust account   1,553,823.18  
Temporary equity stock shares subject to redemption shares 17,235,298    
Temporary equity redemption price per share $ 10.49    
Proceeds from the sale of restricted assets $ 180,900,000    
Subsequent Event [Member] | Sponsor [Member]      
Subsequent Events Details Line Items      
Latest date before which business combination shall be consummated Apr. 22, 2024    
Subsequent Event [Member] | Extension Note [Member] | Sponsor [Member]      
Subsequent Events Details Line Items      
Debt instrument face value   $ 1,553,823.18  
TortoiseEcofin Acquisiti... (NYSE:TRTL)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more TortoiseEcofin Acquisiti... Charts.
TortoiseEcofin Acquisiti... (NYSE:TRTL)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more TortoiseEcofin Acquisiti... Charts.